Institute of Cancer Research Repository - Items where Division or Clinical Unit is: ICR divisions > Cancer Biology > Targeted Therapy ICR divisions > Radiotherapy and Imaging

Items where Division or Clinical Unit is:
ICR divisions > Cancer Biology > Targeted Therapy
ICR divisions > Radiotherapy and Imaging > Targeted Therapy

All teams (392)
- ICR divisions (392)
  - Cancer Biology (392)
    - Targeted Therapy (392)
  - Radiotherapy and Imaging (392)
    - Targeted Therapy (392)

Group by: Authors (ICR Faculty only) | Item Type | No Grouping

Jump to: A | B | D | E | G | H | K | L | M | N | P | W

Number of items at this level: 378.

A

Miles, E. A., Clark, C. H., Urbano, M. T. G., Bidmead, M., Dearnaley, D. P., Harrington, K. J., A'Hern, R., Nutting, C. M. (2005) The impact of introducing intensity modulated radiotherapy into routine clinical practice. RADIOTHERAPY AND ONCOLOGY, 77 (3). pp. 241-246. ISSN 0167-8140

Urbano, T. G., Clark, C. H., Hansen, V. N., Adams, E. J., A'Hern, R., Miles, E. A., McNair, H., Bidmead, M., Warrington, A. P., Dearnaley, D. P., Harrington, K. J., Nutting, C. M. (2007) A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. RADIOTHERAPY AND ONCOLOGY, 85 (1). pp. 36-41. ISSN 0167-8140

Box, C., Mendiola, M., Gowan, S., Box, G. M., Valenti, M., Brandon, A. D., Al-Lazikani, B., Rogers, S. J., Wilkins, A., Harrington, K. J., Eccles, S. A. (2013) A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma. EUROPEAN JOURNAL OF CANCER, 49 (11). pp. 2512-2521. ISSN 0959-8049

B

Burley, T. A., Maczynska, J., Shah, A., Szopa, W., Harrington, K. J., Boult, J. K. R., Mrozek-Wilczkiewicz, A., Vinci, M., Bamber, J. C., Kaspera, W., Kramer-Marek, G. (2018) Near-infrared photoimmunotherapy targeting EGFRShedding new light on glioblastoma treatment. INTERNATIONAL JOURNAL OF CANCER, 142 (11). pp. 2363-2374. ISSN 0020-7136

Urbano, T. G., Clark, C. H., Hansen, V. N., Adams, E. J., Miles, E. A., Mc Nair, H., Bidmead, A. M., Warrington, J., Dearnaley, D. P., Harmer, C., Harrington, K. J., Nutting, C. M. (2007) Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: Acute toxicity results of a phase I study. RADIOTHERAPY AND ONCOLOGY, 85 (1). pp. 58-63. ISSN 0167-8140

Guerrero Urbano, T., Clark, C., Bidmead, M., Dearnaley, D., Harrington, K., Nutting, C. (2005) Intensity Modulated Radiotherapy in Cancer of the Larynx. In: Image Guided IMRT. Springer, Berlin, Germany, 335 - 344. ISBN 978-354020511-1

Humphreys, M., Urbano, M. T. G., Mubata, C., Mites, E., Harrington, K. J., Bidmead, M., Nutting, C. M. (2005) Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imaging. RADIOTHERAPY AND ONCOLOGY, 77 (1). pp. 39-44. ISSN 0167-8140

Clark, C. H., Miles, E. A., Bidmead, A. M., Mubata, C. D., Harrington, K. J., Nutting, C. M. (2003) In regard to Lee et al., IJROBP 2002;53 : 630-637. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 55 (4). p. 1150. ISSN 0360-3016

Clark, C. H., Bidmead, A. M., Mubata, C. D., Harrington, K. J., Nutting, C. M. (2004) Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. RADIOTHERAPY AND ONCOLOGY, 70 (2). pp. 189-198. ISSN 0167-8140

D

Vidal, L., Pandha, H. S., Yap, T. A., White, C. L., Twigger, K., Vile, R. G., Melcher, A., Coffey, M., Harrington, K. J., DeBono, J. S. (2008) A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer. CLINICAL CANCER RESEARCH, 14 (21). pp. 7127-7137. ISSN 1078-0432

Errington, F., Steele, L., Prestwich, R., Harrington, K. J., Pandha, H. S., Vidal, L., de Bono, J., Selby, P., Coffey, M., Vile, R., Melcher, A. (2008) Reovirus activates human dendritic cells to promote innate antitumor immunity. JOURNAL OF IMMUNOLOGY, 180 (9). pp. 6018-6026. ISSN 0022-1767

Yap, T. A., Brunetto, A., Pandha, H., Harrington, K., de Bono, J. S. (2008) Reovirus therapy in cancer: has the orphan virus found a home? EXPERT OPINION ON INVESTIGATIONAL DRUGS, 17 (12). pp. 1925-1935. ISSN 1354-3784

Comins, C., Heinemann, L., Harrington, K., Melcher, A., De Bono, J., Pandha, H. (2008) Reovirus: Viral therapy for cancer 'as nature intended'. CLINICAL ONCOLOGY, 20 (7). pp. 548-554. ISSN 0936-6555

Vidal, L., Yap, T. A., White, C. L., Twigger, K., Hingorani, M., Agrawal, V., Kaye, S. B., Harrington, K. J., de Bono, J. S. (2006) Reovirus and other oncolytic viruses for the targeted treatment of cancer. TARGETED ONCOLOGY, 1 (3). pp. 130-150. ISSN 1776-2596

Wedlake, L., McGough, C., Hackett, C., Thomas, K., Blake, P., Harrington, K., Tait, D., Khoo, V., Dearnaley, D., Andreyev, H. J. N. (2008) Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa? ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 27 (10). pp. 980-987. ISSN 0269-2813

Urbano, M. T. G., Henrys, A. J., Adams, E. J., Norman, A. R., Bedford, J. L., Harrington, K. J., Nutting, C. M., Dearnaley, D. P., Tait, D. M. (2006) Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 65 (3). pp. 907-916. ISSN 0360-3016

Panek, R., Welsh, L., Dunlop, A., Wong, K. H., Riddell, A. M., Koh, D. M., Schmidt, M. A., Doran, S., McQuaid, D., Hopkinson, G., Richardson, C., Nutting, C. M., Bhide, S. A., Harrington, K. J., Robinson, S. P., Newbold, K. L., Leach, M. O. (2016) Repeatability and Sensitivity of T-2* Measurements in Patients With Head and Neck Squamous Cell Carcinoma at 3T. JOURNAL OF MAGNETIC RESONANCE IMAGING, 44 (1). pp. 72-80. ISSN 1053-1807

E

Kirby, A. M., A'Hern, R. P., D'Ambrosio, C., Tanay, M., Syrigos, K. N., Rogers, S. J., Box, C., Eccles, S. A., Nutting, C. M., Harrington, K. J. (2006) Gefitinib (ZD1839, Iressa(TM)) as palliative treatment in recurrent or metastatic head and neck cancer. BRITISH JOURNAL OF CANCER, 94 (5). pp. 631-636. ISSN 0007-0920

Rogers, S. J., Box, C., Harrington, K. J., Nutting, C., Rhys-Evans, P., Eccles, S. A. (2005) The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. EXPERT OPINION ON THERAPEUTIC TARGETS, 9 (4). pp. 769-790. ISSN 1472-8222

G

Touchefeu, Y., Khan, A. A., Borst, G., Zaidi, S. H., McLaughlin, M., Roulstone, V., Mansfield, D., Kyula, J., Pencavel, T., Karapanagiotou, E. M., Clayton, J., Federspiel, M. J., Russell, S. J., Garrett, M., Collins, I., Harrington, K. J. (2013) Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. RADIOTHERAPY AND ONCOLOGY, 108 (1). pp. 24-31. ISSN 0167-8140

Ross, P. J., Teoh, E. M., A'Hern, R. P., Rhys-Evans, P. H., Harrington, K. J., Nutting, C. M., Gore, M. E. (2009) Epirubicin, Cisplatin and Protracted Venous Infusion 5-Fluorouracil Chemotherapy for Advanced Salivary Adenoid Cystic Carcinoma. CLINICAL ONCOLOGY, 21 (4). pp. 311-314. ISSN 0936-6555

H

Miah, A. B., Gulliford, S. L., Morden, J., Newbold, K. L., Bhide, S. A., Zaidi, S. H., Hall, E., Harrington, K. J., Nutting, C. M. (2016) Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy. CLINICAL ONCOLOGY, 28 (9). E69-E76. ISSN 0936-6555

Harrington, K., Hall, E., Hawkins, M., Henry, A., MacKay, R., Maughan, T., McDonald, A., Nutting, C., Oelfke, U., Sebag-Montefiore, D., Sharma, R. A., van Herk, M., Faivre-Finn, C., Comm, Art-Net Steering (2017) Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET). CLINICAL ONCOLOGY, 29 (11). pp. 707-710. ISSN 0936-6555

Dwivedi, R. C., St Rose, S., Chisholm, E. J., Clarke, P. M., Kerawala, C. J., Nutting, C. M., Rhys-Evans, P. H., Kazi, R., Harrington, K. J. (2016) Acoustic parameters of speech: Lack of correlation with perceptual and questionnaire-based speech evaluation in patients with oral and oropharyngeal cancer treated with primary surgery. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38 (5). pp. 670-676. ISSN 1043-3074

Allin, D. M., Shaikh, R., Carter, P., Thway, K., Sharabiani, M. T. A., Gonzales-de-Castro, D., O'Leary, B., Garcia-Murillas, I., Bhide, S., Hubank, M., Harrington, K., Kim, D., Newbold, K. (2018) Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. EUROPEAN JOURNAL OF CANCER, 103. pp. 165-175. ISSN 0959-8049

Sharma, R. A., Plummer, R., Stock, J. K., Greenhalgh, T. A., Ataman, O., Kelly, S., Clay, R., Adams, R. A., Baird, R. D., Billingham, L., Brown, S. R., Buckland, S., Bulbeck, H., Chalmers, A. J., Clack, G., Cranston, A. N., Damstrup, L., Ferraldeschi, R., Forster, M. D., Golec, J., Hagan, R. M., Hall, E., Hanauske, A. R., Harrington, K. J., Haswell, T., Hawkins, M. A., Illidge, T., Jones, H., Kennedy, A. S., McDonald, F., Melcher, T., O'Connor, J. P. B., Pollard, J. R., Saunders, M. P., Sebag-Montefiore, D., Smitt, M., Staffurth, J., Stratford, I. J., Wedge, S. R., Worki, Ncri CTRad Acad-Pharma Joint (2016) Clinical development of new drug-radiotherapy combinations. NATURE REVIEWS CLINICAL ONCOLOGY, 13 (10). pp. 627-642. ISSN 1759-4774

Hafsi, H., Dillon, M. T., Barker, H. E., Kyula, J. N., Schick, U., Paget, J. T., Smith, H. G., Pedersen, M., McLaughlin, M., Harrington, K. J. (2018) Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status. FRONTIERS IN ONCOLOGY, 8. ISSN 2234-943X

Andtbacka, R. H. I., Agarwala, S. S., Ollila, D. W., Hallmeyer, S., Milhem, M., Amatruda, T., Nemunaitis, J. J., Harrington, K. J., Chen, L. S., Shilkrut, M., Ross, M., Kaufman, H. L. (2016) Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38 (12). pp. 1752-1758. ISSN 1043-3074

Gronhoj, C., Jensen, D. H., Dehlendorff, C., Marklund, L., Wagner, S., Mehanna, H., Munck-Wikland, E., Ramqvist, T., Nasman, A., Wittekindt, C., Wurdemann, N., Sharma, S. J., Gattenlohner, S., Kiss, K., Andersen, E., Spruce, R., Batis, N., Robinson, M., Harrington, K., Winter, S., Jones, T. M., Klussmann, J. P., Dalianis, T., Friborg, J., von Buchwald, C. (2018) Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams). BRITISH JOURNAL OF CANCER, 118 (12). pp. 1672-1681. ISSN 0007-0920

Harrington, K. J., Bourhis, J. (2016) Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out? Reply. JOURNAL OF CLINICAL ONCOLOGY, 34 (17). pp. 2073-2074. ISSN 0732-183X

Harrington, K. J., Andtbacka, O. H. I., Collichio, F., Downey, G., Chen, L. S., Szabo, Z., Kaufman, H. L. (2016) Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial. Oncotargets and Therapy, 9. pp. 7081-7093. ISSN 1178-6930

McEntee, G., Kyula, J. N., Mansfield, D., Smith, H., Wilkinson, M., Gregory, C., Roulstone, V., Coffey, M., Harrington, K. J. (2016) Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling. Oncotarget, 7 (30). pp. 48517-48532. ISSN 1949-2553

Mehanna, H., Franklin, N., Compton, N., Robinson, M., Powell, N., Biswas-Baldwin, N., Paleri, V., Hartley, A., Fresco, L., Al-Booz, H., Junor, E., El-Hariry, I., Roberts, S., Harrington, K., Ang, K. K., Dunn, J., Woodman, C. (2016) Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38. E1863-E1869. ISSN 1043-3074

Harrington, K. (2017) IMMUNOTHERAPY LINKED TO IMPROVED QUALITY OF LIFE OUTCOMES FOR PATIENTS WITH ADVANCED HEAD AND NECK CANCER, STUDY FINDS. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 148 (9). pp. 632-633. ISSN 0002-8177

Alharbi, R. A., Pandha, H. S., Simpson, G. R., Pettengell, R., Poterlowicz, K., Thompson, A., Harrington, K., El-Tanani, M., Morgan, R. (2017) Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells. ONCOTARGET, 8 (52). pp. 89566-89579. ISSN 1949-2553

Lee, A. W., Ng, W. T., Pan, J. J., Poh, S. S., Ahn, Y. C., AlHussain, H., Corry, J., Grau, C., Gregoire, V., Harrington, K. J., Hu, C. S., Kwong, D. L., Langendijk, J. A., Le, Q. T., Lee, N. Y., Lin, J. C., Lu, T. X., Mendenhall, W. M., O'Sullivan, B., Ozyar, E., Peters, L. J., Rosenthal, D. I., Soong, Y. L., Tao, Y. G., Yom, S. S., Wee, J. T. (2018) International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. RADIOTHERAPY AND ONCOLOGY, 126 (1). pp. 25-36. ISSN 0167-8140

Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., Worden, F., Saba, N. F., Docampo, L. C. I., Haddad, R., Rordorf, T., Kiyota, N., Tahara, M., Monga, M., Lynch, M., Geese, W. J., Kopit, J., Shaw, J. W., Gillison, M. L. (2016) Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. NEW ENGLAND JOURNAL OF MEDICINE, 375 (19). pp. 1856-1867. ISSN 0028-4793

Harrington, K. J., Ferris, R. L., Blumenschein, G., Colevas, A. D., Fayette, J., Licitra, L., Kasper, S., Even, C., Vokes, E. E., Worden, F., Saba, N. F., Kiyota, N., Haddad, R., Tahara, M., Grunwald, V., Shaw, J. W., Monga, M., Lynch, M., Taylor, F., DeRosa, M., Morrissey, L., Cocks, K., Gillison, M. L., Guigay, J. (2017) Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. LANCET ONCOLOGY, 18 (8). pp. 1104-1115. ISSN 1470-2045

Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K. J., Kasper, S., Vokes, E. E., Even, C., Worden, F., Saba, N. F., Docampo, L. C. I., Haddad, R., Rordorf, T., Kiyota, N., Tahara, M., Lynch, M., Jayaprakash, V., Li, L., Gillison, M. L. (2018) Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. ORAL ONCOLOGY, 81. pp. 45-51. ISSN 1368-8375

Ilett, E., Kottke, T., Thompson, J., Rajani, K., Zaidi, S., Evgin, L., Coffey, M., Ralph, C., Diaz, R., Pandha, H., Harrington, K., Selby, P., Bram, R., Melcher, A., Vile, R. (2017) Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy. GENE THERAPY, 24 (1). pp. 21-30. ISSN 0969-7128

Kottke, T., Evgin, L., Shim, K. G., Rommelfanger, D., Boisgerault, N., Zaidi, S., Diaz, R. M., Thompson, J., Ilett, E., Coffey, M., Selby, P., Pandha, H., Harrington, K., Melcher, A., Vile, R. (2017) Subversion of NK-cell and TNF alpha Immune Surveillance Drives Tumor Recurrence. CANCER IMMUNOLOGY RESEARCH, 5 (11). pp. 1029-1045. ISSN 2326-6066

Sacco, J. J., Evans, M., Harrington, K. J., Man, S., Powell, N., Shaw, R. J., Jones, T. M. (2016) Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001. Human Vaccines & Immunotherapeutics, 12 (4). pp. 1085-1086. ISSN 2164-5515

Morgan, R., El-Tanani, M., Hunter, K. D., Harrington, K. J., Pandha, H. S. (2017) Targeting HOX/PBX dimers in cancer. Oncotarget, 8 (19). pp. 32322-32331. ISSN 1949-2553

Heatley, N., Harrington, K. J., Thway, K. (2018) Warthin Tumor-Like Mucoepidermoid Carcinoma. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 26 (1). pp. 31-33. ISSN 1066-8969

Relph, K. L., Harrington, K. J., Pandha, H. (2005) Adenoviral strategies for the gene therapy of cancer. SEMINARS IN ONCOLOGY, 32 (6). pp. 573-582. ISSN 0093-7754

Seth, R., Khan, A. A., Pencavel, T. D., Wilkinson, M. J., Kyula, J. N., Simpson, G., Pandha, H., Melcher, A., Vile, R., Harris, P. A., Harrington, K. J. (2015) Adenovirally Delivered Enzyme Prodrug Therapy with Herpes Simplex Virus-Thymidine Kinase in Composite Tissue Free Flaps Shows Therapeutic Efficacy in Rat Models of Glioma. PLASTIC AND RECONSTRUCTIVE SURGERY, 135 (2). pp. 475-487. ISSN 0032-1052

Syrigos, K. N., Katirtzoglou, N., Kotteas, E., Harrington, K. (2008) Adhesion molecules in lung cancer: Implications in the pathogenesis and management. CURRENT PHARMACEUTICAL DESIGN, 14 (22). pp. 2173-2183. ISSN 1381-6128

Burtness, B., Bourhis, J. P., Vermorken, J. B., Harrington, K. J., Cohen, E. E. W. (2014) Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial. TRIALS, 15. ISSN 1745-6215

Errington, F., Bateman, A., Kottke, T., Thompson, J., Harrington, K., Merrick, A., Hatfield, P., Selby, P., Vile, R., Melcher, A. (2006) Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy. CLINICAL CANCER RESEARCH, 12 (4). pp. 1333-1341. ISSN 1078-0432

Kottke, T., Hall, G., Pulido, J., Diaz, R. M., Thompson, J., Chong, H., Selby, P., Coffey, M., Pandha, H., Chester, J., Melcher, A., Harrington, K., Vile, R. (2010) Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. JOURNAL OF CLINICAL INVESTIGATION, 120 (5). pp. 1551-1560. ISSN 0021-9738

Kottke, T., Pulido, J., Thompson, J., Sanchez-Perez, L., Chong, H., Calderwood, S. K., Selby, P., Harrington, K., Strome, S. E., Melcher, A., Vile, R. G. (2009) Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70-Mediated Inflammatory Killing of Normal Pancreas. CANCER RESEARCH, 69 (19). pp. 7767-7774. ISSN 0008-5472

Merron, A., Baril, P., Martin-Duque, P., de la Vieja, A., Tran, L., Briat, A., Harrington, K. J., McNeish, I. A., Vassaux, G. (2010) Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 37 (7). pp. 1377-1385. ISSN 1619-7070

Chaudhry, S. I., Hooper, S., Nye, E., Williamson, P., Harrington, K., Sahai, E. (2013) Autocrine IL-1 beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine INF alpha, signalling to carcinoma-associated fibroblasts. ONCOGENE, 32 (6). pp. 747-758. ISSN 0950-9232

Syrigos, K. N., Karapanagiotou, E., Boura, P., Manegold, C., Harrington, K. (2011) Bevacizumab-Induced Hypertension Pathogenesis and Management. BIODRUGS, 25 (3). pp. 159-169. ISSN 1173-8804

Syrigos, K. N., Vile, R. G., Peters, A. M., Harrington, K. J. (2003) Biodistribution and pharmacokinetics of In-111-DTPA-labelled pegylated liposomes after intraperitoneal injection. ACTA ONCOLOGICA, 42 (2). pp. 147-153. ISSN 0284-186X

Hingorani, M., Spitzweg, C., Vassaux, G., Newbold, K., Melcher, A., Pandha, H., Vile, R., Harrington, K. (2010) The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery. CURRENT CANCER DRUG TARGETS, 10 (2). pp. 242-267. ISSN 1568-0096

Roulstone, V., Pedersen, M., Kyula, J., Mansfield, D., Khan, A. A., McEntee, G., Wilkinson, M., Karapanagiotou, E., Coffey, M., Marais, R., Jebar, A., Errington-Mais, F., Melcher, A., Vile, R., Pandha, H., McLaughlin, M., Harrington, K. J. (2015) BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress. MOLECULAR THERAPY, 23 (5). pp. 931-942. ISSN 1525-0016

Dunlop, A., Welsh, L., McQuaid, D., Dean, J., Gulliford, S., Hansen, V., Bhide, S., Nutting, C., Harrington, K., Newbold, K. (2015) Brain-Sparing Methods for IMRT of Head and Neck Cancer. PLOS ONE, 10 (3). ISSN 1932-6203

Kottke, T., Errington, F., Pulido, J., Galivo, F., Thompson, J., Wongthida, P., Diaz, R. M., Chong, H., Ilett, E., Chester, J., Pandha, H., Harrington, K., Selby, P., Melcher, A., Vile, R. (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. NATURE MEDICINE, 17 (7). 854-U223. ISSN 1078-8956

Charpidou, A., Gkiozos, I., Konstantinou, M., Eleftheraki, A., Demertzis, P., Harrington, K., Polyzos, A., Syrigos, K. N. (2011) Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients. CANCER LETTERS, 304 (2). pp. 144-153. ISSN 0304-3835

Harrington, K. J., Bateman, A. R., Melcher, A. A., Ahmed, A., Vile, R. G. (2002) Cancer gene therapy: Part 1. Vector development and regulation of gene expression. CLINICAL ONCOLOGY, 14 (1). pp. 3-16. ISSN 0936-6555

Harrington, K. J., Melcher, A. A., Bateman, A. R., Ahmed, A., Vile, R. G. (2002) Cancer gene therapy: Part 2. Candidate transgenes and their clinical development. CLINICAL ONCOLOGY, 14 (2). pp. 148-169. ISSN 0936-6555

Prestwich, R. J., Errington, F., Diaz, R. M., Pandha, H. S., Harrington, K. J., Melcher, A. A., Vile, R. G. (2009) The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon. HUMAN GENE THERAPY, 20 (10). pp. 1119-1132. ISSN 1043-0342

Adair, R. A., Roulstone, V., Scott, K. J., Morgan, R., Nuovo, G. J., Fuller, M., Beirne, D., West, E. J., Jennings, V. A., Rose, A., Kyula, J., Fraser, S., Dave, R., Anthoney, D. A., Merrick, A., Prestwich, R., Aldouri, A., Donnelly, O., Pandha, H., Coffey, M., Selby, P., Vile, R., Toogood, G., Harrington, K., Melcher, A. A. (2012) Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients. Science Translational Medicine, 4 (138). ISSN 1946-6242

Willmon, C., Harrington, K., Kottke, T., Prestwich, R., Melcher, A., Vile, R. (2009) Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy. MOLECULAR THERAPY, 17 (10). pp. 1667-1676. ISSN 1525-0016

Harrington, K., Alvarez-Vallina, L., Crittenden, M., Gough, M., Chong, W. H., Diaz, R. M., Vassaux, G., Lemoine, N., Vile, R. (2002) Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? HUMAN GENE THERAPY, 13 (11). pp. 1263-1280. ISSN 1043-0342

Syrigos, K. N., Harrington, K. J., Karayiannakis, A. J., Baibas, N., Katirtzoglou, N., Roussou, P. (2004) Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma. ANTICANCER RESEARCH, 24 (3B). pp. 2027-2031. ISSN 0250-7005

Harrington, K. J., Puzanov, I., Hecht, J. R., Hodi, F. S., Szabo, Z., Murugappan, S., Kaufman, H. L. (2015) Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy. EXPERT REVIEW OF ANTICANCER THERAPY, 15 (12). pp. 1389-1403. ISSN 1473-7140

Syrigos, K. N., Karapanagiotou, E., Harrington, K. J. (2004) The clinical significance of molecular markers to bladder cancer. HYBRIDOMA AND HYBRIDOMICS, 23 (6). pp. 335-342. ISSN 1536-8599

Terpos, E., Kiagia, M., Karapanagiotou, E. M., Charpidou, A., Dilana, K. D., Nasothimiou, E., Harrington, K. J., Polyzos, A., Syrigos, K. N. (2009) The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications. ANTICANCER RESEARCH, 29 (5). pp. 1651-1657. ISSN 0250-7005

Harrington, K. J., Vile, R. G., Melcher, A., Chester, J., Pandha, H. S. (2010) Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics. CYTOKINE & GROWTH FACTOR REVIEWS, 21 (2-3, S). pp. 91-98. ISSN 1359-6101

Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S. I., Williamson, P., Harrington, K., Leitinger, B., Sahai, E. (2011) Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. NATURE CELL BIOLOGY, 13 (1). 49-U123. ISSN 1072-8368

Simpson, G. R., Horvath, A., Annels, N. E., Pencavel, T., Metcalf, S., Seth, R., Peschard, P., Price, T., Coffin, R. S., Mostafid, H., Melcher, A. A., Harrington, K. J., Pandha, H. S. (2012) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. BRITISH JOURNAL OF CANCER, 106 (3). pp. 496-507. ISSN 0007-0920

Rajani, K., Parrish, C., Kottke, T., Thompson, J., Zaidi, S., Ilett, L., Shim, K. G., Diaz, R. M., Pandha, H., Harrington, K., Coffey, M., Melcher, A., Vile, R. (2016) Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses. MOLECULAR THERAPY, 24 (1). pp. 166-174. ISSN 1525-0016

Hingorani, M., White, C. L., Agrawal, V. K., Vidal, L., Melcher, A., Harrington, K. J. (2007) Combining radiation and cancer gene therapy: A potential marriage of physical and biological targeting? CURRENT CANCER DRUG TARGETS, 7 (4). pp. 389-409. ISSN 1568-0096

Ahmed, A., Thompson, J., Emiliusen, L., Murphy, S., Beauchamp, R. D., Suzuki, K., Alemany, R., Harrington, K., Vile, R. G. (2003) A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization. NATURE BIOTECHNOLOGY, 21 (7). pp. 771-777. ISSN 1087-0156

Ilett, E., Kottke, T., Donnelly, O., Thompson, J., Willmon, C., Diaz, R., Zaidi, S., Coffey, M., Selby, P., Harrington, K., Pandha, H., Melcher, A., Vile, R. (2014) Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus. MOLECULAR THERAPY, 22 (10). pp. 1851-1863. ISSN 1525-0016

Adair, R. A., Scott, K. J., Fraser, S., Errington-Mais, F., Pandha, H., Coffey, M., Selby, P., Cook, G. P., Vile, R., Harrington, K. J., Toogood, G., Melcher, A. A. (2013) Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells. INTERNATIONAL JOURNAL OF CANCER, 132 (10). pp. 2327-2338. ISSN 0020-7136

Syrigos, K. N., Sitara, D., Georgiou, E., Harrington, K. J. (2002) Cytotoxic therapy of gastroenteropancreatic (GEP) tumours. ANTICANCER RESEARCH, 22 (2B). pp. 1311-1314. ISSN 0250-7005

Blanchard, M., Shim, K. G., Grams, M. P., Rajani, K., Diaz, R. M., Furutani, K. M., Thompson, J., Olivier, K. R., Park, S. S., Markovic, S. N., Pandha, H., Melcher, A., Harrington, K., Zaidi, S., Vile, R. (2015) Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93 (3). pp. 577-587. ISSN 0360-3016

Ilett, E. J., Prestwich, R. J., Kottke, T., Errington, F., Thompson, J. M., Harrington, K. J., Pandha, H. S., Coffey, M., Selby, P. J., Vile, R. G., Melcher, A. A. (2009) Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. GENE THERAPY, 16 (5). pp. 689-699. ISSN 0969-7128

Melcher, A., Bateman, A., Harrington, K., Ahmed, A., Gough, M., Vile, R. (2002) Dendritic cells for the immunotherapy of cancer. CLINICAL ONCOLOGY, 14 (3). pp. 185-192. ISSN 0936-6555

Kottke, T., Boisgerault, N., Diaz, R. M., Donnelly, O., Rommelfanger-Konkol, D., Pulido, J., Thompson, J., Mukhopadhyay, D., Kaspar, R., Coffey, M., Pandha, H., Melcher, A., Harrington, K., Selby, P., Vile, R. (2013) Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. NATURE MEDICINE, 19 (12). pp. 1625-1631. ISSN 1078-8956

Mubashar, M., Harrington, K. J., Chaudhary, K. S., El-Nasir, L., Stamp, G. W., Peters, A. M. (2004) Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines. ACTA ONCOLOGICA, 43 (5). pp. 443-452. ISSN 0284-186X

Shears, L., Plowright, L., Harrington, K., Pandha, H. S., Morgan, R. (2008) Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P. JOURNAL OF UROLOGY, 180 (5). pp. 2196-2201. ISSN 0022-5347

Heinemann, L., Simpson, G. R., Annels, N. E., Vile, R., Melcher, A., Prestwich, R., Harrington, K. J., Pandha, H. S. (2010) The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis. MOLECULAR THERAPY, 18 (12). pp. 2085-2093. ISSN 1525-0016

Hoskin, P. J., Robinson, M., Slevin, N., Morgan, D., Harrington, K., Gaffney, C. (2009) Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer. JOURNAL OF CLINICAL ONCOLOGY, 27 (34). pp. 5751-5756. ISSN 0732-183X

Bourke, M. G., Salwa, S., Harrington, K. J., Kucharczyk, M. J., Forde, P. F., de Kruijf, M., Soden, D., Tangney, M., Collins, J. K., O'Sullivan, G. C. (2011) The emerging role of viruses in the treatment of solid tumours. CANCER TREATMENT REVIEWS, 37 (8). pp. 618-632. ISSN 0305-7372

Ismail, M., Morgan, R., Harrington, K., Davies, J., Pandha, H. (2009) Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model. CRYOBIOLOGY, 59 (2). pp. 207-213. ISSN 0011-2240

Linardakis, E., Bateman, A., Phan, V., Ahmed, A., Gough, M., Olivier, K., Kennedy, R., Errington, F., Harrington, K. J., Melcher, A., Vile, R. (2002) Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. CANCER RESEARCH, 62 (19). pp. 5495-5504. ISSN 0008-5472

White, C. L., Menghistu, T., Twigger, K. R., Searle, P. F., Bhide, S. A., Vile, R. G., Melcher, A. A., Pandha, H. S., Harrington, K. J. (2008) Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo. GENE THERAPY, 15 (6). pp. 424-433. ISSN 0969-7128

Dwivedi, R. C., St Rose, S., Chisholm, E. J., Bisase, B., Amen, F., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2012) Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients. ORAL ONCOLOGY, 48 (6). pp. 547-553. ISSN 1368-8375

Harrington, K. J., Melcher, A., Vassaux, G., Pandha, H. S., Vile, R. G. (2008) Exploiting synergies between radiation and oncolytic viruses. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 10 (4). pp. 362-370. ISSN 1464-8431

Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., Sahai, E. (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. NATURE CELL BIOLOGY, 9 (12). pp. 1392-1400. ISSN 1465-7392

Boisgerault, N., Kottke, T., Pulido, J., Thompson, J., Diaz, R. M., Rommelfanger-Konkol, D., Embry, A., Saenz, D., Poeschla, E., Pandha, H., Harrington, K., Melcher, A., Selby, P., Vile, R. (2013) Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse. MOLECULAR THERAPY, 21 (8). pp. 1507-1516. ISSN 1525-0016

Errington, F., Jones, J., Merrick, A., Bateman, A., Harrington, K., Gough, M., O'Donnell, D., Selby, P., Vile, R., Melcher, A. (2006) Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming. GENE THERAPY, 13 (2). pp. 138-149. ISSN 0969-7128

Harrington, K. J., Syrigos, K. N. (2002) Gene therapy strategies for lung cancer. PNEUMON, 15 (1). pp. 19-37. ISSN 1105-848X

Good, J. S., Harrington, K. J. (2013) The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology. CLINICAL ONCOLOGY, 25 (10). pp. 569-577. ISSN 0936-6555

Donnelly, O., Vile, R., Pandha, H., Harrington, K., Melcher, A. (2012) The Hitchhiker's Guide to Virotherapy. Oncotarget, 3 (8). pp. 735-736. ISSN 1949-2553

Morgan, R., Simpson, G., Gray, S., Gillett, C., Tabi, Z., Spicer, J., Harrington, K. J., Pandha, H. S. (2016) HOX transcription factors are potential targets and markers in malignant mesothelioma. BMC CANCER, 16. p. 11. ISSN 1471-2407

Plowright, L., Harrington, K. J., Pandha, H. S., Morgan, R. (2009) HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). BRITISH JOURNAL OF CANCER, 100 (3). pp. 470-475. ISSN 0007-0920

Dillon, Magnus T., Harrington, Kevin J. (2015) Human Papillomavirus-Negative Pharyngeal Cancer. JOURNAL OF CLINICAL ONCOLOGY, 33 (29). pp. 3251-61. ISSN 0732-183X

Dillon, M. T., Harrington, K. J. (2015) Human Papillomavirus-Negative Pharyngeal Cancer. JOURNAL OF CLINICAL ONCOLOGY, 33 (29). pp. 3251-3261. ISSN 0732-183X

Prestwich, R. J., Ilett, E. J., Errington, F., Diaz, R. M., Steele, L. P., Kottke, T., Thompson, J., Galivo, F., Harrington, K. J., Pandha, H. S., Selby, P. J., Vile, R. G., Melcher, A. A. (2009) Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication. CLINICAL CANCER RESEARCH, 15 (13). pp. 4374-4381. ISSN 1078-0432

Ismail, M., Morgan, R., Harrington, K., Davies, J., Pandha, H. (2010) Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model. CRYOBIOLOGY, 61 (3). pp. 268-274. ISSN 0011-2240

Merrick, A., Errington, F., Milward, K., O'Donnell, D., Harrington, K., Bateman, A., Pandha, H., Vile, R., Morrison, E., Selby, P., Melcher, A. (2005) Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming. BRITISH JOURNAL OF CANCER, 92 (8). pp. 1450-1458. ISSN 0007-0920

Prestwich, R. J., Harrington, K. J., Vile, R. G., Melcher, A. A. (2008) Immunotherapeutic potential of oncolytic virotherapy. LANCET ONCOLOGY, 9 (7). pp. 610-612. ISSN 1470-2045

Kottke, T., Thompson, J., Diaz, R. M., Pulido, J., Willmon, C., Coffey, M., Selby, P., Melcher, A., Harrington, K., Vile, R. G. (2009) Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2. CLINICAL CANCER RESEARCH, 15 (2). pp. 561-569. ISSN 1078-0432

Kottke, T., Sanchez-Perez, L., Diaz, R. M., Thompson, J., Chong, H., Harrington, K., Calderwood, S. K., Pulido, J., Georgopoulos, N., Selby, P., Melcher, A., Vile, R. (2007) Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. CANCER RESEARCH, 67 (24). pp. 11970-11979. ISSN 0008-5472

Errington, F., White, C. L., Twigger, K. R., Rose, A., Scott, K., Steele, L., Ilett, L. J., Prestwich, R., Pandha, H. S., Coffey, M., Selby, P., Vile, R., Harrington, K. J., Melcher, A. A. (2008) Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. GENE THERAPY, 15 (18). pp. 1257-1270. ISSN 0969-7128

Ismail, M., Bokaee, S., Davies, J., Harrington, K. J., Pandha, H. (2009) Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. BRITISH JOURNAL OF CANCER, 100 (12). pp. 1889-1895. ISSN 0007-0920

Ismail, M., Bokaee, S., Morgan, R., Davies, J., Harrington, K. J., Pandha, H. (2009) Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy (vol 100, pg 1889, 2009). [Correction]

Harrington, K. J., Nutting, C. M. (2002) Interactions between ionising radiation and drugs in head and neck cancer - how can we maximize the therapeutic index? CURRENT OPINION IN INVESTIGATIONAL DRUGS (LONDON, ENGLAND: 2000), 3 (5). pp. 807-811. ISSN 1472-4472

Ahmed, A., Jevremovic, D., Suzuki, K., Kottke, T., Thompson, J., Emery, S., Harrington, K., Bateman, A., Vile, R. (2003) Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy. GENE THERAPY, 10 (19). pp. 1663-1671. ISSN 0969-7128

Pencavel, T. D., Wilkinson, M. J., Mansfield, D. C., Khan, A. A., Seth, R., Karapanagiotou, E. M., Roulstone, V., Aguilar, R. J., Chen, N. G., Szalay, A. A., Hayes, A. J., Harrington, K. J. (2015) Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma. INTERNATIONAL JOURNAL OF CANCER, 136 (4). pp. 965-976. ISSN 0020-7136

Perlikos, F., Harrington, K. J., Syrigos, K. N. (2013) Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 87 (1). pp. 1-11. ISSN 1040-8428

Harrington, K. J. (2001) Liposomal cancer chemotherapy: current clinical applications and future prospects. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 10 (6). pp. 1045-1061. ISSN 1354-3784

Donnelly, O., Harrington, K., Melcher, A., Pandha, H. (2013) Live viruses to treat cancer. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 106 (8). pp. 310-314. ISSN 0141-0768

Pencavel, T., Seth, R., Hayes, A., Melcher, A., Pandha, H., Vile, R., Harrington, K. J. (2010) Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow? GENE THERAPY, 17 (8). pp. 949-960. ISSN 0969-7128

Jennings, V. A., Ilett, E. J., Scott, K. J., West, E. J., Vile, R., Pandha, H., Harrington, K., Young, A., Hall, G. D., Coffey, M., Selby, P., Errington-Mais, F., Melcher, A. A. (2014) Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. INTERNATIONAL JOURNAL OF CANCER, 134 (5). pp. 1091-1101. ISSN 0020-7136

Donnelly, O. G., Errington-Mais, F., Steele, L., Hadac, E., Jennings, V., Scott, K., Peach, H., Phillips, R. M., Bond, J., Pandha, H., Harrington, K., Vile, R., Russell, S., Selby, P., Melcher, A. A. (2013) Measles virus causes immunogenic cell death in human melanoma. GENE THERAPY, 20 (1). pp. 7-15. ISSN 0969-7128

Touchefeu, Y., Schick, U., Harrington, K. J. (2012) Measles virus: a future therapeutic agent in oncology? M S-MEDECINE SCIENCES, 28 (4). pp. 388-394. ISSN 0767-0974

Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., Sahai, E. (2013) Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. NATURE CELL BIOLOGY, 15 (6). 637-U441. ISSN 1465-7392

Harrington, K., Jankowska, P., Hingorani, M. (2007) Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer. CLINICAL ONCOLOGY, 19 (8). pp. 561-571. ISSN 0936-6555

Sarris, E. G., Harrington, K. J., Saif, M. W., Syrigos, K. N. (2014) Multimodal treatment strategies for elderly patients with head and neck cancer. CANCER TREATMENT REVIEWS, 40 (3). pp. 465-475. ISSN 0305-7372

Zaidi, S., Blanchard, M., Shim, K., Ilett, E., Rajani, K., Parrish, C., Boisgerault, N., Kottke, T., Thompson, J., Celis, E., Pulido, J., Selby, P., Pandha, H., Melcher, A., Harrington, K., Vile, R. (2015) Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine melanoma Model After Treatment With Immunomodulatory Agents. MOLECULAR THERAPY, 23 (5). pp. 845-856. ISSN 1525-0016

Kazi, R., Singh, A., De Cordova, J., Clarke, P., Harrington, K. J., Rhys-Evans, P. (2005) A new self-administered questionnaire to determine patient experience with voice prostheses (Blom-Singer valves). JOURNAL OF POSTGRADUATE MEDICINE, 51 (4). pp. 253-258. ISSN 0022-3859

Kyula, J. N., Roulstone, V., Karapanagiotou, E. M., Melcher, A. A., Harrington, K. J. (2012) Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer. EXPERT OPINION ON BIOLOGICAL THERAPY, 12 (12). pp. 1669-1678. ISSN 1471-2598

Mansfield, D., Pencavel, T., Kyula, J. N., Zaidi, S., Roulstone, V., Thway, K., Karapanagiotou, L., Khan, A. A., McLaughlin, M., Touchefeu, Y., Seth, R., Melcher, A. A., Vile, R. G., Pandha, H. S., Harrington, K. J. (2013) Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. ORAL ONCOLOGY, 49 (2). pp. 108-118. ISSN 1368-8375

Harrington, K. J. (2013) Oncolytic Virotherapy Needs Trials, Not Access Programs. CLINICAL CANCER RESEARCH, 19 (10). pp. 2595-2597. ISSN 1078-0432

Touchefeu, Y., Vassaux, G., Harrington, K. J. (2011) Oncolytic viruses in radiation oncology. RADIOTHERAPY AND ONCOLOGY, 99 (3). pp. 262-270. ISSN 0167-8140

Prestwich, R. J., Harrington, K. J., Pandha, H. S., Vile, R. G., Melcher, A. A., Errington, F. (2008) Oncolytic viruses: a novel form of immunotherapy. EXPERT REVIEWS IN ANTICANCER THERAPY, 8 (10). pp. 1581-1588. ISSN 1473-7140

Pandha, H., Melcher, A., Harrington, K., Vile, R. (2009) Oncolytic Viruses: Time to Compare, Contrast, and Combine? MOLECULAR THERAPY, 17 (6). pp. 934-935. ISSN 1525-0016

Patel, R., Barker, H. E., Kyula, J., McLaughlin, M., Dillon, M. T., Schick, U., Hafsi, H., Thompson, A., Khoo, V., Harrington, K., Zaidi, S. (2017) An orally bioavailable Chkl inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. RADIOTHERAPY AND ONCOLOGY, 122 (3). pp. 470-475. ISSN 0167-8140

Bhide, S. A., Harrington, K. J., Nutting, C. M. (2007) Otological toxicity after postoperative radiotherapy for parotid tumours. CLINICAL ONCOLOGY, 19 (1). pp. 77-82. ISSN 0936-6555

Macpherson, I. R., Hooper, S., Serrels, A., McGarry, L., Ozanne, B. W., Harrington, K., Frame, M. C., Sahai, E., Brunton, V. G. (2007) p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism. ONCOGENE, 26 (36). pp. 5214-5228. ISSN 0950-9232

Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., Vile, R. G., Peters, A. M., Stewart, J. S. (2001) Phase I-II study of pegylated liposomal ciplastin (SPI-077) in patients with inoperable head and neck cancer. ANNALS OF ONCOLOGY, 12 (4). pp. 493-496. ISSN 0923-7534

Senzer, N. N., Kaufman, H. L., Amatruda, T., Nemunaitis, M., Reid, T., Daniels, G., Gonzalez, R., Glaspy, J., Whitman, E., Harrington, K., Goldsweig, H., Marshall, T., Love, C., Coffin, R., Nemunaitis, J. J. (2009) Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma. JOURNAL OF CLINICAL ONCOLOGY, 27 (34). pp. 5763-5771. ISSN 0732-183X

Galanis, E., Markovic, S. N., Suman, V. J., Nuovo, G. J., Vile, R. G., Kottke, T. J., Nevala, W. K., Thompson, M. A., Lewis, J. E., Rumilla, K. M., Roulstone, V., Harrington, K., Linette, G. P., Maples, W. J., Coffey, M., Zwiebel, J., Kendra, K. (2012) Phase II Trial of Intravenous Administration of Reolysin (R) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma. MOLECULAR THERAPY, 20 (10). pp. 1998-2003. ISSN 1525-0016

Harrington, K. J., Mubashar, M., Peters, A. M. (2002) Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules - lessons from liposomes and monoclonal antibodies. THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE : OFFICIAL PUBLICATION OF THE ITALIAN ASSOCIATION OF NUCLEAR MEDICINE (AIMN) [AND] THE INTERNATIONAL ASSOCIATION OF RADIOPHARMACOLOGY (IAR), 46 (3). pp. 171-180. ISSN 1125-0135

Harrington, K., Temam, S., Mehanna, H., D'Cruz, A., Jain, M., D'Onofrio, I., Manikhas, G., Horvath, Z., Sun, Y., Dietzsch, S., Dubinsky, P., Holeckova, P., El-Hariry, I., Franklin, N., Biswas-Baldwin, N., Legenne, P., Wissel, P., Netherway, T., Farrell, J., Ellis, C., Wang-Silvanto, J., Amonkar, M., Ahmed, N., Santillana, S., Bourhis, J. (2015) Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study. JOURNAL OF CLINICAL ONCOLOGY, 33 (35). pp. 4202-4209. ISSN 0732-183X

Harrington, K. J., Michielin, O., Malvehy, J., Gruter, I. P., Grove, L., Frauchiger, A. L., Dummer, R. (2017) A practical guide to the handling and administration of talimogene laherparepvec in Europe. ONCOTARGETS AND THERAPY, 10. pp. 3867-3880. ISSN 1178-6930

Kottke, T., Chester, J., Ilett, E., Thompson, J., Diaz, R., Coffey, M., Selby, P., Nuovo, G., Pulido, J., Mukhopadhyay, D., Pandha, H., Harrington, K., Melcher, A., Vile, R. (2011) Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy. MOLECULAR THERAPY, 19 (10). pp. 1802-1812. ISSN 1525-0016

Harrington, K. J., Nutting, C. M., Archer, D. J. (2004) Primary malignant melanoma arising in the dorsum of the tongue. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 42 (1). pp. 78-79. ISSN 0266-4356

Steele, L., Errington, F., Prestwich, R., Ilett, E., Harrington, K., Pandha, H., Coffey, M., Selby, P., Vile, R., Melcher, A. (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming. Molecular Cancer, 10. ISSN 1476-4598

Alonso-Camino, V., Rajani, K., Kottke, T., Rommelfanger-Konkol, D., Zaidi, S., Thompson, J., Pulido, J., Ilett, E., Donnelly, O., Selby, P., Pandha, H., Melcher, A., Harrington, K., Diaz, R. M., Vile, R. (2014) The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. MOLECULAR THERAPY, 22 (11). pp. 1936-1948. ISSN 1525-0016

Syrigos, K. N., Karapanagiotou, E., Harrington, K. J. (2005) Prostate cancer in the elderly. ANTICANCER RESEARCH, 25 (6C). pp. 4527-4533. ISSN 0250-7005

Qiao, J., Kottke, T., Willmon, C., Galivo, F., Wongthida, P., Diaz, R. M., Thompson, J., Ryno, P., Barber, G. N., Chester, J., Selby, P., Harrington, K., Melcher, A., Vile, R. G. (2008) Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. NATURE MEDICINE, 14 (1). pp. 37-44. ISSN 1078-8956

Kazi, R., Kiverniti, E., De-Cordova, J., Clarke, P., Rhys-Evans, P., Harrington, K. J. (2006) Quality of life assessment in laryngectomized individuals. CLINICAL OTOLARYNGOLOGY, 31 (1). pp. 83-84. ISSN 0307-7772

Hatfield, P., Merrick, A., Harrington, K., Vile, R., Bateman, A., Selby, P., Melcher, A. (2005) Radiation-induced cell death and dendritic cells: Potential for cancer immunotherapy? CLINICAL ONCOLOGY, 17 (1). pp. 1-11. ISSN 0936-6555

Franzese, C., Gujral, D. M., Good, J., Thway, K., Harrington, K. J. (2013) Radical Radiotherapy for Radiation-induced Malignancy in the Context of Hereditary Retinoblastoma. CLINICAL ONCOLOGY, 25 (5). pp. 330-331. ISSN 0936-6555

Touchefeu, Y., Franken, P., Harrington, K. J. (2012) Radiovirotherapy: Principles and Prospects in Oncology. CURRENT PHARMACEUTICAL DESIGN, 18 (22). pp. 3313-3320. ISSN 1381-6128

Harrington, K., Berrier, A., Robinson, M., Remenar, E., Housset, M., de Mendoza, F. H., Fayette, J., Mehanna, H., El-Hariry, I., Compton, N., Franklin, N., Biswas-Baldwin, N., Lau, M., Legenne, P., Kumar, R. (2013) Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease. EUROPEAN JOURNAL OF CANCER, 49 (7). pp. 1609-1618. ISSN 0959-8049

Harrington, K. J. (2010) Rash conclusions from a phase 3 study of cetuximab? LANCET ONCOLOGY, 11 (1). pp. 2-3. ISSN 1470-2045

Relph, K., Harrington, K., Pandha, H. (2004) Recent developments and current status of gene therapy using viral vectors in the United Kingdom. BRITISH MEDICAL JOURNAL, 329 (7470). pp. 839-842. ISSN 0007-1447

Prestwich, R. J., Errington, F., Steele, L. P., Ilett, E. J., Morgan, R. S. M., Harrington, K. J., Pandha, H. S., Selby, P. J., Vile, R. G., Melcher, A. A. (2009) Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus. JOURNAL OF IMMUNOLOGY, 183 (7). pp. 4312-4321. ISSN 0022-1767

Taylor, G. S., Jia, H., Harrington, K., Lee, L. W., Turner, J., Ladell, K., Price, D. A., Tanday, M., Matthews, J., Roberts, C., Edwards, C., McGuigan, L., Hartley, A., Wilson, S., Hui, E. P., Chan, A. T. C., Rickinson, A. B., Steven, N. M. (2014) A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer. CLINICAL CANCER RESEARCH, 20 (19). pp. 5009-5022. ISSN 1078-0432

Comins, C., Spicer, J., Protheroe, A., Roulstone, V., Twigger, K., White, C. M., Vile, R., Melcher, A., Coffey, M. C., Mettinger, K. L., Nuovo, G., Cohn, D. E., Phelps, M., Harrington, K. J., Pandha, H. S. (2010) REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer. CLINICAL CANCER RESEARCH, 16 (22). pp. 5564-5572. ISSN 1078-0432

Twigger, K., Roulstone, V., Kyula, J., Karapanagiotou, E. M., Syrigos, K. N., Morgan, R., White, C., Bhide, S., Nuovo, G., Coffey, M., Thompson, B., Jebar, A., Errington, F., Melcher, A. A., Vile, R. G., Pandha, H. S., Harrington, K. J. (2012) Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC CANCER, 12. ISSN 1471-2407

Touchefeu, Y., Harrington, K. J., Galmiche, J. P., Vassaux, G. (2010) Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 32 (8). pp. 953-968. ISSN 0269-2813

Dillon, M. T., Good, J. S., Harrington, K. J. (2014) Selective Targeting of the G2/M Cell Cycle Checkpoint to Improve the Therapeutic Index of Radiotherapy. CLINICAL ONCOLOGY, 26 (5). pp. 257-265. ISSN 0936-6555

Daniels, G. A., Sanchez-Perez, L., Diaz, R. M., Kottke, T., Thompson, J., Lai, M., Gough, M., Karim, M., Bushell, A., Chong, H., Melcher, A., Harrington, K., Vile, R. G. (2004) A simple method to cure established tumors by inflammatory killing of normal cells. NATURE BIOTECHNOLOGY, 22 (9). pp. 1125-1132. ISSN 1087-0156

Merron, A., Peerlinck, I., Martin-Duque, P., Burnet, J., Quintanilla, M., Mather, S., Hingorani, M., Harrington, K., Iggo, R., Vassaux, G. (2007) SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. GENE THERAPY, 14 (24). pp. 1731-1738. ISSN 0969-7128

Roulstone, V., Twigger, K., Zaidi, S., Pencavel, T., Kyula, J. N., White, C., McLaughlin, M., Seth, R., Karapanagiotou, E. M., Mansfield, D., Coffey, M., Nuovo, G., Vile, R. G., Pandha, H. S., Melcher, A. A., Harrington, K. J. (2013) Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. GENE THERAPY, 20 (5). pp. 521-528. ISSN 0969-7128

Kyula, J. N., Khan, A. A., Mansfield, D., Karapanagiotou, E. M., McLaughlin, M., Roulstone, V., Zaidi, S., Pencavel, T., Touchefeu, Y., Seth, R., Chen, N. G., Yu, Y. A., Zhang, Q., Melcher, A. A., Vile, R. G., Pandha, H. S., Ajaz, M., Szalay, A. A., Harrington, K. J. (2014) Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-alpha signaling. ONCOGENE, 33 (13). pp. 1700-1712. ISSN 0950-9232

Pandha, H. S., Heinemann, L., Simpson, G. R., Melcher, A., Prestwich, R., Errington, F., Coffey, M., Harrington, K. J., Morgan, R. (2009) Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma. CLINICAL CANCER RESEARCH, 15 (19). pp. 6158-6166. ISSN 1078-0432

Heinemann, L., Simpson, G. R., Boxall, A., Kottke, T., Relph, K. L., Vile, R., Melcher, A., Prestwich, R., Harrington, K. J., Morgan, R., Pandha, H. S. (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC CANCER, 11. ISSN 1471-2407

Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., Milhem, M., Cranmer, L., Curti, B., Lewis, K., Ross, M., Guthrie, T., Linette, G. P., Daniels, G. A., Harrington, K., Middleton, M. R., Miller, W. H., Zager, J. S., Ye, Y. N., Yao, B., Li, A., Doleman, S., VanderWalde, A., Gansert, J., Coffin, R. S. (2015) Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. JOURNAL OF CLINICAL ONCOLOGY, 33 (25). pp. 2780-2788. ISSN 0732-183X

Appleton, E. S., Turnbull, S., Ralph, C., West, E., Scott, K., Harrington, K., Pandha, H., Melcher, A. (2015) Talimogene laherparepvec in the treatment of melanoma. EXPERT OPINION ON BIOLOGICAL THERAPY, 15 (10). pp. 1517-1530. ISSN 1471-2598

Seth, R., Khan, A. A., Pencavel, T., Harrington, K. J., Harris, P. A. (2012) Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction. LANCET ONCOLOGY, 13 (9). E392-E402. ISSN 1470-2045

Peerlinck, I., Merron, A., Baril, P., Conchon, S., Martin-Duque, P., Hindorf, C., Burnet, J., Quintanilla, M., Hingorani, M., Iggo, R., Lemoine, N. R., Harrington, K., Vassaux, G. (2009) Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter. CLINICAL CANCER RESEARCH, 15 (21). pp. 6595-6601. ISSN 1078-0432

Harrington, K. J., Syrigos, K. N., Uster, P. S., Zetter, A., Lewanski, C. R., Gullick, W. J., Vile, R. G., Stewart, J. S. W. (2004) Targeted radiosensitisation by pegylated liposome-encapsulated 3 ',5 '-O-dipalmitoyl 5-iodo-2 '-deoxyuridine in a head and neck cancer xenograft model. BRITISH JOURNAL OF CANCER, 91 (2). pp. 366-373. ISSN 0007-0920

Morgan, R., Plowright, L., Harrington, K. J., Michael, A., Pandha, H. S. (2010) Targeting HOX and PBX transcription factors in ovarian cancer. BMC CANCER, 10. ISSN 1471-2407

Morgan, R., Boxall, A., Harrington, K. J., Simpson, G. R., Michael, A., Pandha, H. S. (2014) Targeting HOX transcription factors in prostate cancer. Bmc Urology, 14. ISSN 1471-2490

Morgan, R., Boxall, A., Harrington, K. J., Simpson, G. R., Gillett, C., Michael, A., Pandha, H. S. (2012) Targeting the HOX/PBX dimer in breast cancer. BREAST CANCER RESEARCH AND TREATMENT, 136 (2). pp. 389-398. ISSN 0167-6806

Mubashar, M., Harrington, K. J., Chaudhary, K. S., Lalani, E-N., Stamp, G., Sinnet, D., Glass, D., Peters, A. M. (2002) Tc-99m-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer. JOURNAL OF NUCLEAR MEDICINE, 43 (4). pp. 519-525. ISSN 0161-5505

Harrington, K. J. (2010) Topical treatment for oral cancers Winners and losers and oncolytic adenoviruses: who should be down in the mouth? GENE THERAPY, 17 (12). pp. 1421-1422. ISSN 0969-7128

Schick, U., Kyula, J., Barker, H., Patel, R., Zaidi, S., Gregory, C., Hafsi, H., Roulstone, V., Deutsch, E., McLaughlin, M., Harrington, K. (2015) Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. RADIOTHERAPY AND ONCOLOGY, 117 (2). pp. 364-375. ISSN 0167-8140

Emiliusen, L., Gough, M., Bateman, A., Ahmed, A., Voellmy, R., Chester, J., Diaz, R. M., Harrington, K., Vile, R. (2001) A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component. GENE THERAPY, 8 (13). pp. 987-998. ISSN 0969-7128

Kottke, T., Galivo, F., Wongthida, P., Diaz, R. M., Thompson, J., Jevremovic, D., Barber, G. N., Hall, G., Chester, J., Selby, P., Harrington, K., Melcher, A., Vile, R. G. (2008) Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus. MOLECULAR THERAPY, 16 (7). pp. 1217-1226. ISSN 1525-0016

Chester, J., Ruchatz, A., Gough, M., Crittenden, M., Chong, H., Loic-Cosset, L., Diaz, R. M., Harrington, K., Alvarez-Vallina, L., Vile, R. (2002) Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. NATURE BIOTECHNOLOGY, 20 (3). pp. 256-263. ISSN 1087-0156

Prestwich, R. J., Errington, F., Ilett, E. J., Morgan, R. S. M., Scott, K. J., Kottke, T., Thompson, J., Morrison, E. E., Harrington, K. J., Pandha, H. S., Selby, P. J., Vile, R. G., Melcher, A. A. (2008) Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity. CLINICAL CANCER RESEARCH, 14 (22). pp. 7358-7366. ISSN 1078-0432

Barker, H. E., Paget, J. T. E., Khan, A. A., Harrington, K. J. (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. NATURE REVIEWS CANCER, 15 (7). pp. 409-425. ISSN 1474-175X

Harrington, K. J., Syrigos, K. N., Vile, R. G. (2002) Uposomally targeted cytotoxic drugs for the treatment of cancer. JOURNAL OF PHARMACY AND PHARMACOLOGY, 54 (12). pp. 1573-1600. ISSN 0022-3573

Kottke, T., Diaz, R. M., Kaluza, K., Pulido, J., Galivo, F., Wongthida, P., Thompson, J., Willmon, C., Barber, G. N., Chester, J., Selby, P., Strome, S., Harrington, K., Melcher, A., Vile, R. G. (2008) Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer. MOLECULAR THERAPY, 16 (12). pp. 1910-1918. ISSN 1525-0016

Richard-Fiardo, P., Franken, P. R., Harrington, K. J., Vassaux, G., Cambien, B. (2011) The use of molecular imaging of gene expression by radiotracers in gene therapy. EXPERT OPINION ON BIOLOGICAL THERAPY, 11 (10). pp. 1273-1285. ISSN 1471-2598

Pulido, J., Kottke, T., Thompson, J., Galivo, F., Wongthida, P., Diaz, R. M., Rommelfanger, D., Ilett, E., Pease, L., Pandha, H., Harrington, K., Selby, P., Melcher, A., Vile, R. (2012) Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. NATURE BIOTECHNOLOGY, 30 (4). pp. 336-343. ISSN 1087-0156

Willmon, C., Diaz, R. M., Wongthida, P., Galivo, F., Kottke, T., Thompson, J., Albelda, S., Harrington, K., Melcher, A., Vile, R. (2011) Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide. MOLECULAR THERAPY, 19 (1). pp. 140-149. ISSN 1525-0016

Harrington, K., Vile, R. (2006) Virus smuggling, tax evasion and tumor assassination. NATURE MEDICINE, 12 (5). pp. 507-509. ISSN 1078-8956

Kazi, R., Johnson, C., Prasad, V., De Cordova, J., Venkitaraman, R., Nutting, C. M., Clarke, P., Evans, P. R., Harrington, K. J. (2008) Quality of life outcome measures following partial glossectomy: Assessment using the UW-QOL scale. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 4 (3). pp. 116-120. ISSN 0973-1482

White, C. L., Twigger, K. R., Vidal, L., De Bono, J. S., Coffey, M., Heinemann, L., Morgan, R., Merrick, A., Errington, F., Vile, R. G., Melcher, A. A., Pandha, H. S., Harrington, K. J. (2008) Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. GENE THERAPY, 15 (12). pp. 911-920. ISSN 0969-7128

Qiao, J., Wang, H. X., Kottke, T., White, C., Twigger, K., Diaz, R. M., Thompson, J., Selby, P., de Bono, J., Melcher, A., Pandha, H., Coffey, M., Vile, R., Harrington, K. (2008) Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. CLINICAL CANCER RESEARCH, 14 (1). pp. 259-269. ISSN 1078-0432

Twigger, K., Vidal, L., White, C. L., De Bono, J. S., Bhide, S., Coffey, M., Thompson, B., Vile, R. G., Heinemann, L., Pandha, H. S., Errington, F., Melcher, A. A., Harrington, K. J. (2008) Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. CLINICAL CANCER RESEARCH, 14 (3). pp. 912-923. ISSN 1078-0432

Lolkema, M. P., Arkenau, H. T., Harrington, K., Roxburgh, P., Morrison, R., Roulstone, V., Twigger, K., Coffey, M., Mettinger, K., Gill, G., Evans, T. R. J., de Bono, J. S. (2011) A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer. CLINICAL CANCER RESEARCH, 17 (3). pp. 581-588. ISSN 1078-0432

Gami, B., Harrington, K., Blake, P., Dearnaley, D., Tait, D., Davies, J., Norman, A. R., Andreyev, H. J. N. (2003) How patients manage gastrointestinal symptoms after pelvic radiotherapy. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 18 (10). pp. 987-994. ISSN 0269-2813

Rogers, S. J., Harrington, K. J., Rhys-Evans, P., Charoenrat, P. O., Eccles, S. A. (2005) Biological significance of c-erbB family oncogenes in head and neck cancer. CANCER AND METASTASIS REVIEWS, 24 (1). pp. 47-69. ISSN 0167-7659

Rogers, S. J., Harrington, K. J., Eccles, S. A., Nutting, C. M. (2004) Combination epidermal growth factor receptor inhibition and radical radiotherapy for NSCLC. EXPERT REVIEW OF ANTICANCER THERAPY, 4 (4). pp. 569-583. ISSN 1473-7140

Luangdilok, S., Box, C., Harrington, K., Rhys-Evans, P., Eccles, S. (2011) MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. EUROPEAN JOURNAL OF CANCER, 47 (4). pp. 520-529. ISSN 0959-8049

Luangdilok, S., Box, C., Patterson, L., Court, W., Harrington, K., Pitkin, L., Rhys-Evans, P., O-charoenrat, P., Eccles, S. (2007) Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. CANCER RESEARCH, 67 (16). pp. 7907-7916. ISSN 0008-5472

Agaimy, A., Fonseca, I., Martins, C., Thway, K., Barrette, R., Harrington, K. J., Hartmann, A., French, C. A., Fisher, C. (2018) NUT Carcinoma of the Salivary Glands Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 42 (7). pp. 877-884. ISSN 0147-5185

Mansfield, D. C., Kyula, J. N., Rosenfelder, N., Chao-Chu, J., Kramer-Marek, G., Khan, A. A., Roulstone, V., McLaughlin, M., Melcher, A. A., Vile, R. G., Pandha, H. S., Khoo, V., Harrington, K. J. (2016) Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer. GENE THERAPY, 23 (4). pp. 357-368. ISSN 0969-7128

Khattak, M., Gore, M., Larkin, J., Strauss, D., Thomas, M., Hayes, A., Harrington, K. (2012) Adjuvant nodal irradiation in melanoma. LANCET ONCOLOGY, 13 (8). E326-E327. ISSN 1470-2045

Wilkinson, M. J., Smith, H. G., McEntee, G., Kyula-Currie, J., Pencavel, T. D., Mansfield, D. C., Khan, A. A., Roulstone, V., Hayes, A. J., Harrington, K. J. (2016) Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis. Oncotarget, 7 (49). pp. 81208-81222. ISSN 1949-2553

McGough, C., Wedlake, L., Baldwin, C., Hackett, C., Norman, A. R., Blake, P., Harrington, K., Tait, D., Khoo, V., Frost, G., Andreyev, H. J. N. (2008) Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 27 (11). pp. 1132-1139. ISSN 0269-2813

McGough, C., Baldwin, C., Norman, A., Frost, G., Blake, P., Tait, D., Khoo, V., Harrington, K., Andreyev, H. J. (2006) Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy? CLINICAL NUTRITION, 25 (1). pp. 109-116. ISSN 0261-5614

Khalid, U., McGough, C., Hackett, C., Blake, P., Harrington, K. J., Khoo, V. S., Tait, D., Norman, A. R., Andreyev, H. J. N. (2006) A modified Inflammatory Bowel Disease Questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 64 (5). pp. 1432-1441. ISSN 0360-3016

McGough, C., Peacock, N., Hackett, C., Baldwin, C., Norman, A., Frost, G., Blake, P., Tait, D., Khoo, V., Harrington, K., Whelan, K., Andreyev, H. J. N. (2006) Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: A double-blind controlled study. CLINICAL NUTRITION, 25 (6). pp. 906-912. ISSN 0261-5614

Martins, C. D., Da Pieve, C., Burley, T. A., Smith, R., Ciobota, D. M., Allott, L., Harrington, K. J., Oyen, W. J. G., Smith, G., Kramer-Marek, G. (2018) HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging. CLINICAL CANCER RESEARCH, 24 (8). pp. 1853-1865. ISSN 1078-0432

Yip, K., Melcher, A., Harrington, K., Illidge, T., Nobes, J., Webster, A., Smith, D., Lorigan, P., Nathan, P., Larkin, J. (2018) Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial. CLINICAL ONCOLOGY, 30 (4). pp. 201-203. ISSN 0936-6555

Ahmed, M., Barbachano, Y., Riddell, A., Hickey, J., Newbold, K. L., Viros, A., Harrington, K. J., Marais, R., Nutting, C. M. (2011) Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 165 (2). pp. 315-322. ISSN 0804-4643

Mavria, G., Harrington, K. J., Marshall, C. J., Porter, C. D. (2005) In vivo efficacy of HSV-TK transcriptionally targeted to the tumour vasculature is augmented by combination with cytotoxic chemotherapy. JOURNAL OF GENE MEDICINE, 7 (3). pp. 263-275. ISSN 1099-498X

Khan, A. A., Paget, J. T., McLaughlin, M., Kyula, J. N., Wilkinson, M. J., Pencavel, T., Mansfield, D., Roulstone, V., Seth, R., Halle, M., Somaiah, N., Boult, J. K. R., Robinson, S. P., Pandha, H. S., Vile, R. G., Melcher, A. A., Harris, P. A., Harrington, K. J. (2018) Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Science Translational Medicine, 10 (425). ISSN 1946-6242

Kottke, T., Shim, K. G., Alonso-Camino, V., Zaidi, S., Diaz, R. M., Pulido, J., Thompson, J., Rajani, K. R., Evgin, L., Ilett, E., Pandha, H., Harrington, K., Selby, P., Melcher, A., Vile, R. (2016) Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular Therapy-Oncolytics, 3. ISSN 2372-7705

Annels, N. E., Arif, M., Simpson, G. R., Denyer, M., Moller-Levet, C., Mansfield, D., Butler, R., Shafren, D., Au, G., Knowles, M., Harrington, K., Vile, R., Melcher, A., Pandha, H. (2018) Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. MOLECULAR THERAPY-ONCOLYTICS, 9. pp. 1-12. ISSN 2372-7705

Comins, C., Simpson, G. R., Rogers, W., Relph, K., Harrington, K., Melcher, A., Roulstone, V., Kyula, J., Pandha, H. (2018) Synergistic antitumour effects of rapamycin and oncolytic reovirus. CANCER GENE THERAPY, 25 (5). pp. 148-160. ISSN 0929-1903

Dean, J. A., Welsh, L. C., McQuaid, D., Wong, K. H., Aleksic, A., Dunne, E., Islam, M. R., Patel, A., Patel, P., Petkar, I., Phillips, I., Sham, J., Newbold, K. L., Bhide, S. A., Harrington, K. J., Gulliford, S. L., Nutting, C. M. (2016) Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. RADIOTHERAPY AND ONCOLOGY, 119 (1). pp. 166-171. ISSN 0167-8140

Barker, H. E., Patel, R., McLaughlin, M., Schick, U., Zaidi, S., Nutting, C. M., Newbold, K. L., Bhide, S., Harrington, K. J. (2016) CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy. MOLECULAR CANCER THERAPEUTICS, 15 (9). pp. 2042-2054. ISSN 1535-7163

Gujral, D. M., Cheung, W. K., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Hooper, J., Senior, R., Tang, M. X., Harrington, K. J., Nutting, C. M. (2016) Contrast enhancement of carotid adventitial vasa vasorum as a biomarker of radiation-induced atherosclerosis. RADIOTHERAPY AND ONCOLOGY, 120 (1). pp. 63-68. ISSN 0167-8140

Bhide, S. A., Thway, K., Lee, J., Wong, K., Clarke, P., Newbold, K. L., Nutting, C. M., Harrington, K. J. (2016) Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma. BRITISH JOURNAL OF CANCER, 115 (7). pp. 825-830. ISSN 0007-0920

McQuaid, D., Dunlop, A., Nill, S., Franzese, C., Nutting, C. M., Harrington, K. J., Newbold, K. L., Bhide, S. A. (2016) Evaluation of radiotherapy techniques for radical treatment of lateralised oropharyngeal cancers. STRAHLENTHERAPIE UND ONKOLOGIE, 192 (8). pp. 516-525. ISSN 0179-7158

Schache, A. G., Powell, N. G., Cuschieri, K. S., Robinson, M., Leary, S., Mehanna, H., Rapozo, D., Long, A., Cubie, H., Junor, E., Monaghan, H., Harrington, K. J., Nutting, C. M., Schick, U., Lau, A. S., Upile, N., Sheard, J., Brougham, K., West, C. M. L., Oguejiofor, K., Thomas, S., Ness, A. R., Pring, M., Thomas, G. J., King, E. V., McCance, D. J., James, J. A., Moran, M., Sloan, P., Shaw, R. J., Evans, M., Jones, T. M. (2016) HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology. CANCER RESEARCH, 76 (22). pp. 6598-6606. ISSN 0008-5472

McLaughlin, M., Barker, H. E., Khan, A. A., Pedersen, M., Dillon, M., Mansfield, D. C., Patel, R., Kyula, J. N., Bhide, S. A., Newbold, K. L., Nutting, C. M., Harrington, K. J. (2017) HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation. BMC CANCER, 17. ISSN 1471-2407

Miah, A. B., Bhide, S. A., Del Rosario, L., Matthews, J., Nicol, R., Tanay, M. A., Gupta, S., Zaidi, S. H., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2016) Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer. CLINICAL ONCOLOGY, 28 (8). E61-E67. ISSN 0936-6555

Rooney, K. P., Miah, A. B., Bhide, S. A., Guerrero-Urbano, M. T., Sharabiani, M. T., Newbold, K. L., Grove, L., Harrington, K. J., Nutting, C. M. (2018) Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study. RADIOTHERAPY AND ONCOLOGY, 127 (1). pp. 43-48. ISSN 0167-8140

Dean, J. A., Welsh, L. C., Wong, K. H., Aleksic, A., Dunne, E., Islam, M. R., Patel, A., Patel, P., Petkar, I., Phillips, I., Sham, J., Schick, U., Newbold, K. L., Bhide, S. A., Harrington, K. J., Nutting, C. M., Gulliford, S. L. (2017) Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. CLINICAL ONCOLOGY, 29 (4). pp. 263-273. ISSN 0936-6555

Dean, J. A., Wong, K. H., Welsh, L. C., Jones, A. B., Schick, U., Newbold, K. L., Bhide, S. A., Harrington, K. J., Nutting, C. M., Gulliford, S. L. (2016) Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy. RADIOTHERAPY AND ONCOLOGY, 120 (1). pp. 21-27. ISSN 0167-8140

Shah, B. N., Gujral, D. M., Chahal, N. S., Harrington, K. J., Nutting, C. M., Senior, R. (2016) Plaque Neovascularization Is Increased in Human Carotid Atherosclerosis Related to Prior Neck Radiotherapy A Contrast-Enhanced Ultrasound Study. Jacc-Cardiovascular Imaging, 9 (6). pp. 668-675. ISSN 1936-878X

Petkar, I., Bhide, S., Newbold, K., Harington, K., Nutting, C. (2018) Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom. BRITISH JOURNAL OF RADIOLOGY, 91 (1085). ISSN 0007-1285

Dillon, M. T., Barker, H. E., Pedersen, M., Hafsi, H., Bhide, S. A., Newbold, K. L., Nutting, C. M., McLaughlin, M., Harrington, K. J. (2017) Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei. MOLECULAR CANCER THERAPEUTICS, 16 (1). pp. 25-34. ISSN 1535-7163

Roe, J. W. G., Carding, P. N., Drinnan, M. J., Harrington, K. J., Nutting, C. M. (2016) Swallowing performance and tube feeding status in patients treated with parotid-sparing intensity-modulated radiotherapy for head and neck cancer. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38. E1436-E1444. ISSN 1043-3074

Richards, T. M., Bhide, S. A., Miah, A. B., Del Rosario, L., Bodla, S., Thway, K., Gujral, D. M., Rooney, K. P., Schick, U., McGovern, T., Grove, L., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2016) Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies. CLINICAL ONCOLOGY, 28 (9). E77-E84. ISSN 0936-6555

Gujral, D. M., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Senior, R., Harrington, K. J., Nutting, C. M. (2016) Arterial Stiffness as a Biomarker of Radiation-Induced Carotid Atherosclerosis. ANGIOLOGY, 67 (3). pp. 266-271. ISSN 0003-3197

Roe, J. W. G., Carding, P. N., Rhys-Evans, P. H., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2012) Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom - A web-based survey. ORAL ONCOLOGY, 48 (4). pp. 343-348. ISSN 1368-8375

Cheung, W. K., Gujral, D. M., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Cosgrove, D. O., Eckersley, R. J., Harrington, K. J., Senior, R., Nutting, C. M., Tang, M. X. (2015) ATTENUATION CORRECTION AND NORMALISATION FOR QUANTIFICATION OF CONTRAST ENHANCEMENT IN ULTRASOUND IMAGES OF CAROTID ARTERIES. ULTRASOUND IN MEDICINE AND BIOLOGY, 41 (7). pp. 1876-1883. ISSN 0301-5629

Harrington, K. J., Nutting, C. M. (2010) Bravo for PRAVO. LANCET ONCOLOGY, 11 (5). pp. 407-408. ISSN 1470-2045

Kazi, R., Singh, A., Mullan, G. P. J., Venkitaraman, R., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J. (2006) Can objective parameters derived from videofluoroscopic assessment of post-laryngectomy valved speech replace current subjective measures? An e-tool-based analysis. CLINICAL OTOLARYNGOLOGY, 31 (6). pp. 518-524. ISSN 0307-7772

Bhide, S. A., Gulliford, S., Fowler, J., Rosenfelder, N., Newbold, K., Harrington, K. J., Nutting, C. M. (2010) Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy. RADIOTHERAPY AND ONCOLOGY, 97 (1, Sp.). pp. 86-91. ISSN 0167-8140

Gujral, D. M., Shah, B. N., Chahal, N. S., Senior, R., Harrington, K. J., Nutting, C. M. (2014) Clinical Features of Radiation-induced Carotid Atherosclerosis. CLINICAL ONCOLOGY, 26 (2). pp. 94-102. ISSN 0936-6555

Bhide, S. A., Gulliford, S., Kazi, R., El-Hariry, I., Newbold, K., Harrington, K. J., Nutting, C. M. (2009) Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. RADIOTHERAPY AND ONCOLOGY, 93 (3). pp. 539-544. ISSN 0167-8140

Michalaki, V. J., Hall, J., Henk, J. M., Nutting, C. M., Harrington, K. J. (2003) Definitive radiotherapy for extramedullary plasmacytomas of the head and neck. BRITISH JOURNAL OF RADIOLOGY, 76 (910). pp. 738-741. ISSN 0007-1285

Dwivedi, R. C., St Rose, S., Chisholm, E. J., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2012) DEVELOPMENT AND VALIDATION OF FIRST-EVER SPEECH-SPECIFIC PERCEPTUAL SPEECH EVALUATION TOOL FOR PATIENTS WITH HEAD AND NECK CANCER: THE LONDON SPEECH EVALUATION (LSE) SCALE. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 34 (1). pp. 94-103. ISSN 1043-3074

Singh, A., Kazi, R., Venkitaraman, R., Kapoor, K., Nutting, C., Clarke, P., Rhys, E. P., Harrington, K. (2008) Does flexible videostroboscopy compare with rigid videostroboscopy in the assessment of the neoglottis? A preliminary report. CLINICAL OTOLARYNGOLOGY, 33 (1). pp. 60-63. ISSN 0307-7772

Bhide, S. A., Gulliford, S., Schick, U., Miah, A., Zaidi, S., Newbold, K., Nutting, C. M., Harrington, K. J. (2012) Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer. RADIOTHERAPY AND ONCOLOGY, 103 (1). pp. 88-91. ISSN 0167-8140

Miah, A. B., Gulliford, S. L., Clark, C. H., Bhide, S. A., Zaidi, S. H., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2013) Dose-response analysis of parotid gland function: What is the best measure of xerostomia? RADIOTHERAPY AND ONCOLOGY, 106 (3). pp. 341-345. ISSN 0167-8140

del Campo, J. M., Hitt, R., Sebastian, P., Carracedo, C., Lokanatha, D., Bourhis, J., Temam, S., Cupissol, D., De Raucourt, D., Maroudias, N., Nutting, C. M., Compton, N., Midwinter, D., Downie, L., Biswas-Baldwin, N., El-Hariry, I., Harrington, K. J. (2011) Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. BRITISH JOURNAL OF CANCER, 105 (5). pp. 618-627. ISSN 0007-0920

Kazi, R., Singh, A., Al-Mutairy, A., De Cordova, J., O'Leary, L., Nutting, C., Clarke, P., Evans, P. R., Harrington, K. (2008) Electroglottographic analysis of valved speech following total laryngectomy. LOGOPEDICS PHONIATRICS VOCOLOGY, 33 (1). pp. 12-21. ISSN 1401-5439

Kazi, R., Venkitaraman, R., Johnson, C., Prasad, V., Clarke, P., Rhys-Evans, P., Nutting, C. M., Harrington, K. J. (2008) Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 70 (2). pp. 344-352. ISSN 0360-3016

Wong, K. H., Panek, R., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L. (2017) The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective. BRITISH JOURNAL OF RADIOLOGY, 90 (1071). ISSN 0007-1285

Dwivedi, R. C., St Rose, S., Chisholm, E. J., Georgalas, C., Bisase, B., Amen, F., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2012) Evaluation of Swallowing by Sydney Swallow Questionnaire (SSQ) in Oral and Oropharyngeal Cancer Patients Treated with Primary Surgery. Dysphagia, 27 (4). pp. 491-497. ISSN 0179-051X

Otter, S., Schick, U., Gulliford, S., Lal, P., Franceschini, D., Newbold, K., Nutting, C., Harrington, K., Bhide, S. (2015) Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93 (3). pp. 507-515. ISSN 0360-3016

Scott-Brown, M., Miah, A., Harrington, K., Nutting, C. (2010) Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy. RADIOTHERAPY AND ONCOLOGY, 97 (2). pp. 249-257. ISSN 0167-8140

Dwivedi, R. C., Chisholm, E. J., Khan, A. S., Harris, N. J., Bhide, S. A., St Rose, S., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2012) An exploratory study of the influence of clinico-demographic variables on swallowing and swallowing-related quality of life in a cohort of oral and oropharyngeal cancer patients treated with primary surgery. European Archives of Oto-Rhino-Laryngology, 269 (4). pp. 1233-1239. ISSN 0937-4477

Powell, C., Newbold, K., Harrington, K. J., Bhide, S. A., Nutting, C. M. (2010) External Beam Radiotherapy for Differentiated Thyroid Cancer. CLINICAL ONCOLOGY, 22 (6, Sp.). pp. 456-463. ISSN 0936-6555

Khan, A., Smellie, J., Nutting, C., Harrington, K., Newbold, K. (2010) Familial Nonmedullary Thyroid Cancer: A Review of the Genetics. THYROID, 20 (7). pp. 795-801. ISSN 1050-7256

Dwivedi, R. C., St Rose, S., Roe, J. W., Chisholm, E., Elmiyeh, B., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2010) First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. ISSN 1043-3074

Lee, B., Cook, G., John, L., Harrington, K., Nutting, C. (2008) Follicular thyroid carcinoma metastasis to the esophagus detected by (18)FDG PET/CT. THYROID, 18 (2). pp. 267-271. ISSN 1050-7256

Harrington, K. J., Nutting, C. M., Pandha, H. S. (2005) Gene therapy for head and neck cancer. CANCER AND METASTASIS REVIEWS, 24 (1). pp. 147-164. ISSN 0167-7659

Harrington, K. J., Billingham, L. J., Brunner, T. B., Burnet, N. G., Chan, C. S., Hoskin, P., Mackay, R. I., Maughan, T. S., Macdougall, J., McKenna, W. G., Nutting, C. M., Oliver, A., Plummer, R., Stratford, I. J., Illidge, T., Radiot, Ncri Clinical Translational (2011) Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. BRITISH JOURNAL OF CANCER, 105 (5). pp. 628-639. ISSN 0007-0920

Dandekar, P., Harmer, C., Barbachano, Y., Rhys-Evans, P., Harrington, K., Nutting, C., Newbold, K. (2009) HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR ANAPLASTIC THYROID CARCINOMA: TOXICITY AND SURVIVAL ANALYSIS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 74 (2). pp. 518-521. ISSN 0360-3016

Nutting, C., Harrington, K. (2004) In regards to Dr. Glatstein Int J Radiat Oncol Biol Phys 2003;55:561-562, and Dr. Amols, Int J Radiat Oncol Biol Phys 2003;56:1507. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 58 (4). pp. 1316-1317. ISSN 0360-3016

Pandha, H., D'Ambrosio, C., Heenan, S., Hyde, N., Di Palma, S., Nutting, C., Relph, K., Harrington, K. (2009) Indium-labelled Autologous Dendritic Cells Migrate to Local Lymph Nodes after Intratumoural Injection in Head and Neck Cancer Patients. CLINICAL ONCOLOGY, 21 (4). pp. 363-364. ISSN 0936-6555

Bhide, S., Clark, C., Harrington, K., Nutting, C. M. (2007) Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. MEDICAL DOSIMETRY, 32 (3). pp. 188-195. ISSN 0958-3947

Manikantan, K., Khode, S., Dwivedi, R. C., Palav, R., Nutting, C. M., Rhys-Evans, P., Harrington, K. J., Kazi, R. (2009) Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. CANCER TREATMENT REVIEWS, 35 (8). pp. 744-753. ISSN 0305-7372

Mendes, R. L., Nutting, C. M., Harrington, K. J. (2002) Managing side effects of radiotherapy in head and neck cancer. HOSPITAL MEDICINE (LONDON, ENGLAND: 1998), 63 (12). pp. 712-717. ISSN 1462-3935

Kazi, R., Kiverniti, E., Prasad, V., Venkitaraman, R., Nutting. C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J. (2006) Multidimensional assessment of female tracheoesophageal prosthetic speech. CLINICAL OTOLARYNGOLOGY, 31 (6). pp. 511-517. ISSN 0307-7772

Lynch, J., Lal, P., Schick, U., Nutting, C. M., Newbold, K., Harrington, K., Bhide, S. (2014) Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. ORAL ONCOLOGY, 50 (9). pp. 901-906. ISSN 1368-8375

Welsh, L. C., Dunlop, A. W., McGovern, T., McQuaid, D., Dean, J. A., Gulliford, S. L., Bhide, S. A., Harrington, K. J., Nutting, C. M., Newbold, K. L. (2014) Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer. CLINICAL ONCOLOGY, 26 (12). pp. 765-775. ISSN 0936-6555

Dean, J. A., Welsh, L. C., Gulliford, S. L., Harrington, K. J., Nutting, C. M. (2015) A novel method for delineation of oral mucosa for radiotherapy dose-response studies. RADIOTHERAPY AND ONCOLOGY, 115 (1). pp. 63-66. ISSN 0167-8140

Harrington, K. J., Kazi, R., Bhide, S. A., Newbold, K., Nutting, C. M. (2010) Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents. INDIAN JOURNAL OF CANCER, 47 (3). pp. 248-259. ISSN 0019-509X

Roe, J. W. G., Drinnan, M. J., Carding, P. N., Harrington, K. J., Nutting, C. M. (2014) Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia? ORAL ONCOLOGY, 50 (12). pp. 1182-1187. ISSN 1368-8375

Harrington, K.J., El-Hariry, I.A., Holford, C.S., Lusinchi, A., Nutting, C.M., Rosine, D., Tanay, M., Deutsch, E., Matthews, J., D'Ambrosio, C., Turner, S.J., Pandeshwara, J.S., Bourhis, J. (2009) Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. JOURNAL OF CLINICAL ONCOLOGY, 27 (7). pp. 1100-1107. ISSN 0732-183X

Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., Guest, P. J., Harrington, K. J., James, N. D., Love, C. A., McNeish, I., Medley, L. C., Michael, A., Nutting, C. M., Pandha, H. S., Shorrock, C. A., Simpson, J., Steiner, J., Steven, N. M., Wright, D., Coombes, R. C. (2006) A phase I study of OncoVEX(GM-CSF), a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. CLINICAL CANCER RESEARCH, 12 (22). pp. 6737-6747. ISSN 1078-0432

Harrington, K. J., Hingorani, M., Tanay, M. A., Hickey, J., Bhide, S. A., Clarke, P. M., Renouf, L. C., Thway, K., Sibtain, A., McNeish, I. A., Newbold, K. L., Goldsweig, H., Coffin, R., Nutting, C. M. (2010) Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck. CLINICAL CANCER RESEARCH, 16 (15). pp. 4005-4015. ISSN 1078-0432

Kazi, R., Kanagalingam, J., Al-Mutairy, A., Nutting, C. M., Clarke, P., Rhys-Evans, P. H., Harrington, K. J. (2006) Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. CLINICAL OTOLARYNGOLOGY, 31 (1). p. 83. ISSN 0307-7772

Newbold, K. L., Bhide, S., Convery, H., Harrington, K. J., Nutting, C. M. (2012) Prospective intra-patient evaluation of a shoulder retraction device for radiotherapy in head and neck cancer. MEDICAL DOSIMETRY, 37 (3). pp. 293-295. ISSN 0958-3947

Kazi, R., Venkitaraman, R., Johnson, C., Prasad, V., Clarke, P., Newbold, K., Rhys-Evans, P., Nutting, C., Harrington, K. (2008) Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. RADIOTHERAPY AND ONCOLOGY, 87 (2). pp. 230-236. ISSN 0167-8140

Sayed, S. I., Elmiyeh, B., Rhys-Evans, P., Syrigos, K. N., Nutting, C. M., Harrington, K. J., Kazi, R. (2009) Quality of life and outcomes research in head and neck cancer: A review of the state of the discipline and likely future directions. CANCER TREATMENT REVIEWS, 35 (5). pp. 397-402. ISSN 0305-7372

Kazi, R., De Cordova, J., Kanagalingam, J., Venkitaraman, R., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J. (2007) Quality of life following total laryngectomy: Assessment using the UW-QOL scale. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 69 (2). pp. 100-106. ISSN 0301-1569

Kazi, R., Prasad, V., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P., Harrington, K. J. (2006) Questionnaire analysis of the swallowing-related outcomes following total laryngectomy. CLINICAL OTOLARYNGOLOGY, 31 (6). pp. 525-530. ISSN 0307-7772

Bhide, S. A., Miah, A. B., Harrington, K. J., Newbold, K. L., Nutting, C. M. (2009) Radiation-induced Xerostomia: Pathophysiology, Prevention and Treatment. CLINICAL ONCOLOGY, 21 (10). pp. 737-744. ISSN 0936-6555

Maughan, T. S., Illidge, T. M., Hoskin, P., McKenna, W. G., Brunner, T. B., Stratford, I. J., Harrington, K. J., Plummer, R., Billingham, L. J., Nutting, C., Burnet, N. G., Mackay, R. I., Oliver, A., Young, C., Chan, C. S. K., NCRI Clinical Translational Radiot, [Group Author] (2010) Radiotherapy Research Priorities for the UK. CLINICAL ONCOLOGY, 22 (8, Sp.). pp. 707-709. ISSN 0936-6555

Wong, K. H., Kuciejewska, A., Sharabiani, M. T. A., Ng-Cheng-Hin, B., Hoy, S., Hurley, T., Rydon, J., Grove, L., Santos, A., Ryugenji, M., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L. (2017) A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer. RADIOTHERAPY AND ONCOLOGY, 122 (2). pp. 207-211. ISSN 0167-8140

Westbury, C. B., Harrington, K. J., Rhys-Evans, P., Archer, D. J., Searle, A. E., Henk, J. M., Black, C. M., Nutting, C. M. (2003) Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. POSTGRADUATE MEDICAL JOURNAL, 79 (929). pp. 176-177. ISSN 0032-5473

Ahmed, M., Hansen, V. N., Harrington, K. J., Nutting, C. M. (2009) REDUCING THE RISK OF XEROSTOMIA AND MANDIBULAR OSTEORADIONECROSIS: THE POTENTIAL BENEFITS OF INTENSITY MODULATED RADIOTHERAPY IN ADVANCED ORAL CAVITY CARCINOMA. MEDICAL DOSIMETRY, 34 (3). pp. 217-224. ISSN 0958-3947

Mendes, R. L., Nutting, C. M., Harrington, K. J. (2004) Residual or recurrent head and neck cancer presenting with nerve root compression affecting the upper limbs. BRITISH JOURNAL OF RADIOLOGY, 77 (920). pp. 688-690. ISSN 0007-1285

Bhide, S. A., Ahmed, M., Newbold, K., Harrington, K. J., Nutting, C. M. (2012) The role of intensity modulated radiotherapy in advanced oral cavity carcinoma. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 8 (6). pp. 67-71. ISSN 0973-1482

Bhide, S. A., Kazi, R., Newbold, K., Harrington, K. J., Nutting, C. M. (2010) The role of intensity-modulated radiotherapy in head and neck cancer. INDIAN JOURNAL OF CANCER, 47 (3). pp. 267-273. ISSN 0019-509X

Bhide, S. A., Ahmed, M., Barbachano, Y., Newbold, K., Harrington, K. J., Nutting, C. M. (2008) Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. BRITISH JOURNAL OF CANCER, 99 (1). pp. 57-62. ISSN 0007-0920

Kazi, R., Nutting, C. M., Rhys-Evans, P., Harrington, K. J. (2009) Significance and prognostic impact of comorbidity in head and neck cancer. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 5 (3). pp. 145-147. ISSN 0973-1482

Roe, J. W. G., Carding, P. N., Dwivedi, R. C., Kazi, R. A., Rhys-Evans, P. H., Harrington, K. J., Nutting, C. M. (2010) Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer - A systematic review. ORAL ONCOLOGY, 46 (10). pp. 727-733. ISSN 1368-8375

Jankowska, P. J., Kong, C., Burke, K., Harrington, K. J., Nutting, C. (2007) A systematic study of posterior cervical lymph node irradiation with electrons: Conventional versus customized planning. RADIOTHERAPY AND ONCOLOGY, 85 (1). pp. 132-137. ISSN 0167-8140

Hingorani, M., White, C. L., Zaidi, S., Pandha, H. S., Melcher, A. A., Bhide, S. A., Nutting, C. M., Syrigos, K. N., Vile, R. G., Vassaux, G., Harrington, K. J. (2010) Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair. MOLECULAR THERAPY, 18 (9). pp. 1599-1605. ISSN 1525-0016

Sayed, S. I., Manikantan, K., Khode, S., Jagade, M., Kasbekar, V. G., Shah, R., Palav, R. S., Nutting, C. M., Harrington, K. J., Rhys-Evans, P., Kazi, R. (2010) Tracheo-oesophageal Party Wall Thickness in Laryngectomised Patients in India: Implications for Surgical Voice Restoration. JOURNAL OF SURGICAL ONCOLOGY, 101 (1). pp. 78-83. ISSN 0022-4790

Nutting, C. M., Bhide, S. A., Harrington, K. J. (2008) Treatment of head and neck cancer. NEW ENGLAND JOURNAL OF MEDICINE, 358 (10). pp. 1076-1077. ISSN 0028-4793

Creak, A. L., Harrington, K., Nutting, C. (2005) Treatment of recurrent head and neck cancer: Re-irradiation or chemotherapy? CLINICAL ONCOLOGY, 17 (3). pp. 138-147. ISSN 0936-6555

Irune, E., Dwivedi, R. C., Nutting, C. M., Harrington, K. J. (2014) Treatment-related dysgeusia in head and neck cancer patients. CANCER TREATMENT REVIEWS, 40 (9). pp. 1106-1117. ISSN 0305-7372

Harrington, K. J., Karapanagiotou, E. M., Roulstone, V., Twigger, K. R., White, C. L., Vidal, L., Beirne, D., Prestwich, R., Newbold, K., Ahmed, M., Thway, K., Nutting, C. M., Coffey, M., Harris, D., Vile, R. G., Pandha, H. S., DeBono, J. S., Melcher, A. A. (2010) Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers. CLINICAL CANCER RESEARCH, 16 (11). pp. 3067-3077. ISSN 1078-0432

Kazi, R., Singh, A., De Cordova, J., Al-Mutairy, A., Clarke, P., Nutting, C., Rhys-Evans, P., Harrington, K. (2006) Validation of a voice prosthesis questionnaire to assess valved speech and its related issues in patients following total laryngectomy. CLINICAL OTOLARYNGOLOGY, 31 (5). pp. 404-410. ISSN 0307-7772

Dwivedi, R. C., St Rose, S., Roe, J. W. G., Khan, A. S., Pepper, C., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2010) Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. ORAL ONCOLOGY, 46 (4). E10-E14. ISSN 1368-8375

Ahmed, M., Schmidt, M., Sohaib, A., Kong, C., Burke, K., Richardson, C., Usher, M., Brennan, S., Riddell, A., Davies, M., Newbold, K., Harrington, K. J., Nutting, C. M. (2010) The value of magnetic resonance imaging in target volume delineation of base of tongue tumours - A study using flexible surface coils. RADIOTHERAPY AND ONCOLOGY, 94 (2). pp. 161-167. ISSN 0167-8140

Kazi, R., De Cordova, J., Singh, A., Venkitaraman, R., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J. (2007) Voice-related quality of life in laryngectomees: Assessment using the VHI and V-RQOL symptom scales. JOURNAL OF VOICE, 21 (6). pp. 728-734. ISSN 0892-1997

Schick, U., Gujral, D. M., Richards, T. M., Harrington, K. J., Nutting, C. M. (2012) Zalutumumab in head and neck cancer. EXPERT OPINION ON BIOLOGICAL THERAPY, 12 (1). pp. 119-125. ISSN 1471-2598

Hall, C. E. J., Harris, R., A'Hern, R., Archer, D. J., Rhys-Evans, P., Henk, J. M., Harrington, K. J., Nutting, C. M. (2003) Le Fort I osteotomy and low-dose rate Ir-192 brachytherapy for treatment of recurrent nasopharyngeal tumours. RADIOTHERAPY AND ONCOLOGY, 66 (1). pp. 41-48. ISSN 0167-8140

Harrington, K. J., Michalaki, V. J., Vini, L., Nutting, C. M., Syrigos, K. N., A'Hern, R., Harmer, C. L. (2005) Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience. BRITISH JOURNAL OF RADIOLOGY, 78 (929). pp. 405-410. ISSN 0007-1285

Miah, A. B., Schick, U., Bhide, S. A., Guerrero-Urbano, M. T., Clark, C. H., Bidmead, A. M., Bodla, S., Del Rosario, L., Thway, K., Wilson, P., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2015) A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes. BRITISH JOURNAL OF CANCER, 112 (1). pp. 32-38. ISSN 0007-0920

Clark, C. H., Miles, E. A., Urbano, M. T. G., Bhide, S. A., Bidmead, A. M., Harrington, K. J., Nutting, C. M., UK PARSPORT Trial Management Grp C, [Group Author] (2009) Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. BRITISH JOURNAL OF RADIOLOGY, 82 (979). pp. 585-594. ISSN 0007-1285

Dwivedi, R. C., Rose, S. S., Chisholm, E. J., Youssefi, P., Hassan, M. S. U., Khan, A. S., Elmiyeh, B., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2012) Evaluation of factors affecting post-treatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. European Archives of Oto-Rhino-Laryngology, 269 (2). pp. 591-599. ISSN 0937-4477

Hingorani, M., White, C. L., Zaidi, S., Merron, A., Peerlinck, I., Gore, M. E., Nutting, C. M., Pandha, H. S., Melcher, A. A., Vile, R. G., Vassaux, G., Harrington, K. J. (2008) Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: Implications for sodium iodide symporter gene therapy. CLINICAL CANCER RESEARCH, 14 (15). pp. 4915-4924. ISSN 1078-0432

Harrington, K., A'Hern, R., Eisen, T., Nutting, C., Gore, M. (2005) Patient selection for palliative whole-brain radiotherapy based on RTOG recursive partitioning analysis. CLINICAL ONCOLOGY, 17 (2). p. 128. ISSN 0936-6555

Morris, S. L., Low, S. H., A'Hern, R. P., Eisen, T. G., Gore, M. E., Nutting, C. M., Harrington, K. J. (2004) A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. BRITISH JOURNAL OF CANCER, 91 (5). pp. 829-833. ISSN 0007-0920

Gujral, D. M., Piercy, D., Morden, J. P., Emson, M., Hall, E., Miah, A. B., Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2014) Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial. ORAL ONCOLOGY, 50 (2). pp. 141-146. ISSN 1368-8375

Wong, K. H., Panek, R., Welsh, L., McQuaid, D., Dunlop, A., Riddell, A., Murray, I., Du, Y., Chua, S., Koh, D. M., Bhide, S., Nutting, C., Oyen, W. J. G., Harrington, K., Newbold, K. L. (2016) The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with F-18-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. JOURNAL OF NUCLEAR MEDICINE, 57 (12). pp. 1843-1850. ISSN 0161-5505

Newbold, K., Castellano, I., Charles-Edwards, E., Mears, D., Sohaib, A., Leach, M., Rhys-Evans, P., Clarke, P., Fisher, C., Harrington, K., Nutting, C. (2009) AN EXPLORATORY STUDY INTO THE ROLE OF DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OR PERFUSION COMPUTED TOMOGRAPHY FOR DETECTION OF INTRATUMORAL HYPOXIA IN HEAD-AND-NECK CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 74 (1). pp. 29-37. ISSN 0360-3016

Borri, M., Schmidt, M. A., Powell, C., Koh, D. M., Riddell, A. M., Partridge, M., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L., Leach, M. O. (2015) Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data. PLOS ONE, 10 (9). ISSN 1932-6203

Wong, K. H., Panek, R., Dunlop, A., McQuaid, D., Riddell, A., Welsh, L. C., Murray, I., Koh, D. M., Leach, M. O., Bhide, S. A., Nutting, C. M., Oyen, W. J., Harrington, K. J., Newbold, K. L. (2018) Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45 (5). pp. 759-767. ISSN 1619-7070

Newbold, K. L., Partridge, M., Cook, G., Sharma, B., Rhys-Evans, P., Harrington, K. J., Nutting, C. M. (2008) Evaluation of the role of (18)FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. ACTA ONCOLOGICA, 47 (7). pp. 1229-1236. ISSN 0284-186X

Dandekar, P., Partridge, M., Kazi, R., Nutting, C., Harrington, K., Newbold, K. (2010) Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer. INDIAN JOURNAL OF CANCER, 47 (3). pp. 260-266. ISSN 0019-509X

Agrawal, V. K., Copeland, K. M., Barbachano, Y., Rahim, A., Seth, R., White, C. L., Hingorani, M., Nutting, C. M., Kelly, M., Harris, P., Pandha, H., Melcher, A. A., Vile, R. G., Porter, C., Harrington, K. J. (2009) Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery. GENE THERAPY, 16 (1). pp. 78-92. ISSN 0969-7128

Henderson, D. R., Murray, J. R., Gulliford, S. L., Tree, A. C., Harrington, K. J., Van As, N. J. (2018) An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity. CLINICAL ONCOLOGY, 30 (9). pp. 539-547. ISSN 0936-6555

Sundar, R., Valeri, N., Harrington, K. J., Yap, T. A. (2017) Combining Molecularly Targeted Agents: Is More Always. CLINICAL CANCER RESEARCH, 23 (5). pp. 1123-1125. ISSN 1078-0432

Sourisseau, T., Harrington, K. J., Muller, W. J., Marshall, C. J., White, D. E. (2011) Changes in tumor tissue organization in collagen-I sensitize cells to ionizing radiation in an ex vivo model of solid mammary tumor growth and local invasion. CELL CYCLE, 10 (22). pp. 3979-3981. ISSN 1538-4101

Zaidi, S., McLaughlin, M., Bhide, S. A., Eccles, S. A., Workman, P., Nutting, C. M., Huddart, R. A., Harrington, K. J. (2012) The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage. PLOS ONE, 7 (4). ISSN 1932-6203

Zaidi, S. H., Huddart, R. A., Harrington, K. J. (2009) Novel targeted radiosensitisers in cancer treatment. CURRENT DRUG DISCOVERY TECHNOLOGIES, 6 (2). pp. 103-134. ISSN 1570-1638

Tree, A. C., Jones, K., Hafeez, S., Sharabiani, M. T. A., Harrington, K. J., Lalondrelle, S., Ahmed, M., Huddart, R. A. (2018) Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101 (5). pp. 1168-1171. ISSN 0360-3016

K

Hess, V., A'Hern, R., Nasiri, N., King, D. M., Blake, P. R., Barton, D. P. J., Shepherd, J. H., Ind, T., Bridges, J., Harrington, K., Kaye, S. B., Gore, M. E. (2004) Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment. JOURNAL OF CLINICAL ONCOLOGY, 22 (6). pp. 1040-1044. ISSN 0732-183X

Powell, C., Mikropoulos, C., Kaye, S. B., Nutting, C. M., Bhide, S. A., Newbold, K., Harrington, K. J. (2010) Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers. CANCER TREATMENT REVIEWS, 36 (7). pp. 566-575. ISSN 0305-7372

Henderson, D. R., Murray, J. R., Tree, A. C., Riley, U., Rosenfelder, N. A., Murray, D., Khoo, V. S., van As, N. J. (2016) Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate Radiotherapy. CLINICAL ONCOLOGY, 28 (3). pp. 226-227. ISSN 0936-6555

Whitcher, B., Schmid, V. J., Collins, D. J., Orton, M. R., Koh, D. M., de Corcuera, I. D., Parera, M., del Campo, J. M., deSouza, N. M., Leach, M. O., Harrington, K., El-Hariry, I. A. (2011) A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 24 (2). pp. 85-96. ISSN 0968-5243

Panek, R., Welsh, L., Baker, L. C. J., Schmidt, M. A., Wong, K. H., Riddell, A. M., Koh, D. M., Dunlop, A., McQuaid, D., d'Arcy, J. A., Bhide, S. A., Harrington, K. J., Nutting, C. M., Hopkinson, G., Richardson, C., Box, C., Eccles, S. A., Leach, M. O., Robinson, S. P., Newbold, K. L. (2017) Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI. CLINICAL CANCER RESEARCH, 23 (15). pp. 4233-4241. ISSN 1078-0432

L

Wilkins, A., Furness, A., Corbett, R. W., Bloomfield, A., Porta, N., Morris, S., Ali, Z., Larkin, J., Harrington, K. (2015) The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma. BRITISH JOURNAL OF CANCER, 113 (9). pp. 1275-1281. ISSN 0007-0920

Welsh, L., Panek, R., McQuaid, D., Dunlop, A., Schmidt, M., Riddell, A., Koh, D. M., Doran, S., Murray, I., Du, Y., Chua, S., Hansen, V., Wong, K. H., Dean, J., Gulliford, S., Bhide, S., Leach, M. O., Nutting, C., Harrington, K., Newbold, K. (2015) Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study. RADIATION ONCOLOGY, 10. ISSN 1748-717X

M

Borst, G. R., McLaughlin, M., Kyula, J. N., Neijenhuis, S., Khan, A., Good, J., Zaidi, S., Powell, N. G., Meier, P., Collins, I., Garrett, M. D., Verheij, M., Harrington, K. J. (2013) Targeted Radiosensitization by the Chk1 Inhibitor SAR-020106. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85 (4). pp. 1110-1118. ISSN 0360-3016

N

Rogers, S. J., Box, C., Nutting, C. M., Harrington, K. J., Eccles, S. A. (2007) MET and RON Receptor Tyrosine Kinases: Novel Therapeutic Targets in Squamous Cell Carcinoma of the Head and Neck. CURRENT ENZYME INHIBITION, 3 (1). pp. 1-12. ISSN 1573-4080

Karapanagiotou, E. M., Roulstone, V., Twigger, K., Ball, M., Tanay, M., Nutting, C., Newbold, K., Gore, M. E., Larkin, J., Syrigos, K. N., Coffey, M., Thompson, B., Mettinger, K., Vile, R. G., Pandha, H. S., Hall, G. D., Melcher, A. A., Chester, J., Harrington, K. J. (2012) Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies. CLINICAL CANCER RESEARCH, 18 (7). pp. 2080-2089. ISSN 1078-0432

Petkar, I., Bhide, S., Newbold, K., Harrington, K., Nutting, C. (2017) Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it? CLINICAL ONCOLOGY, 29 (7). E110-E118. ISSN 0936-6555

Dean, J. A., Wong, K. H., Gay, H., Welsh, L. C., Jones, A. B., Schick, U., Oh, J. H., Apte, A., Newbold, K. L., Bhide, S. A., Harrington, K. J., Deasy, J. O., Nutting, C. M., Gulliford, S. L. (2016) Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96 (4). pp. 820-831. ISSN 0360-3016

Gujral, D. M., Long, M., Roe, J. W. G., Harrington, K. J., Nutting, C. M. (2017) Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer. CLINICAL ONCOLOGY, 29 (1). pp. 42-50. ISSN 0936-6555

Bhide, S. A., Ahmed, M., Rengarajan, V., Powell, C., Miah, A., Newbold, K., Nutting, C. M., Harrington, K. J. (2009) ANEMIA DURING SEQUENTIAL INDUCTION CHEMOTHERAPY AND CHEMORADIATION FOR HEAD AND NECK CANCER: THE IMPACT OF BLOOD TRANSFUSION ON TREATMENT OUTCOME. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 73 (2). pp. 391-398. ISSN 0360-3016

Kazi, R. A., Prasad, V. M. N., Kanagalingam, J., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J. (2007) Assessment of the formant frequencies in normal and laryngectomized individuals using linear predictive coding. JOURNAL OF VOICE, 21 (6). pp. 661-668. ISSN 0892-1997

Gujral, D. M., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Hooper, J., Senior, R., Harrington, K. J., Nutting, C. M. (2016) Carotid intima-medial thickness as a marker of radiation-induced carotid atherosclerosis. RADIOTHERAPY AND ONCOLOGY, 118 (2). pp. 323-329. ISSN 0167-8140

Manikantan, K., Sayed, S. I., Syrigos, K. N., Rhys-Evans, P., Nutting, C. M., Harrington, K. J., Kazi, R. (2009) Challenges for the future modifications of the TNM staging system for head and neck cancer: Case for a new computational model? CANCER TREATMENT REVIEWS, 35 (7). pp. 639-644. ISSN 0305-7372

Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2012) Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. BRITISH JOURNAL OF RADIOLOGY, 85 (1013). pp. 487-494. ISSN 0007-1285

Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2010) Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers. EXPERT REVIEW OF ANTICANCER THERAPY, 10 (3). pp. 297-300. ISSN 1473-7140

Dwivedi, R. C., Kazi, R., Agrawal, N., Chisholm, E., Rose, S. S., Elmiyeh, B., Rennie, C., Pepper, C., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Nutting, C. M. (2010) Comprehensive review of small bowel metastasis from head and neck squamous cell carcinoma. ORAL ONCOLOGY, 46 (5). pp. 330-335. ISSN 1368-8375

Gujral, D. M., Shah, B. N., Bhattacharyya, S., Senior, R., Harrington, K. J., Nutting, C. M. (2016) Contrast-enhanced ultrasound to assess plaque neovascularization in irradiated carotid arteries. International Journal of Cardiology, 202. pp. 3-4. ISSN 0167-5273

Manikantan, K., Khode, S., Sayed, S. I., Roe, J., Nutting, C. M., Rhys-Evans, P., Harrington, K. J., Kazi, R. (2009) Dysphagia in head and neck cancer. CANCER TREATMENT REVIEWS, 35 (8). pp. 724-732. ISSN 0305-7372

Miah, A. B., Gulliford, S. L., Bhide, S. A., Zaidi, S. H., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2013) The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT. RADIOTHERAPY AND ONCOLOGY, 106 (3). pp. 346-351. ISSN 0167-8140

Kazi, R., Kanagalingam, J., Venkitaraman, R., Prasad, V., Clarke, P., Nutting, C. M., Rhys-Evans, P., Harrington, K. J. (2009) Electroglottographic and Perceptual Evaluation of Tracheoesophageal Speech. JOURNAL OF VOICE, 23 (2). pp. 247-254. ISSN 0892-1997

Wilkins, A. C., Rosenfelder, N., Schick, U., Gupta, S., Thway, K., Nutting, C. M., Harrington, K. J., Newbold, K., Bhide, S. A. (2013) Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: A matched-pair analysis. ORAL ONCOLOGY, 49 (6). pp. 615-619. ISSN 1368-8375

Dwivedi, R. C., Kazi, R. A., Agrawal, N., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J. (2009) Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers. CANCER TREATMENT REVIEWS, 35 (5). pp. 417-424. ISSN 0305-7372

Powell, C., Schick, U., Morden, J. P., Gulliford, S. L., Miah, A. B., Bhide, S., Newbold, K., Harrington, K. J., Nutting, C. M. (2014) Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain. RADIOTHERAPY AND ONCOLOGY, 110 (3). pp. 416-421. ISSN 0167-8140

Gujral, D. M., Miah, A. B., Bodla, S., Richards, T. M., Welsh, L., Schick, U., Powell, C. J., Clark, C. H., Bidmead, M. A., Grove, L., Guerrero-Urbano, T., Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2014) Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers. ORAL ONCOLOGY, 50 (11). pp. 1089-1097. ISSN 1368-8375

Dwivedi, R. C., Rose, S. S., Roe, J. W. G., Chisholm, E., Elmiyeh, B., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2011) FIRST REPORT ON THE RELIABILITY AND VALIDITY OF SPEECH HANDICAP INDEX IN NATIVE ENGLISH-SPEAKING PATIENTS WITH HEAD AND NECK CANCER. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 33 (3). pp. 341-348. ISSN 1043-3074

Syrigos, K. N., Karachalios, D., Karapanagiotou, E. M., Nutting, C. M., Manolopoulos, L., Harrington, K. J. (2009) Head and neck cancer in the elderly: An overview on the treatment modalities. CANCER TREATMENT REVIEWS, 35 (3). pp. 237-245. ISSN 0305-7372

Sayed, S. I., Dwivedi, R. C., Katna, R., Garg, A., Pathak, K. A., Nutting, C. M., Rhys-Evans, P., Harrington, K. J., Kazi, R. (2011) Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. ORAL ONCOLOGY, 47 (4). pp. 237-243. ISSN 1368-8375

Welsh, L., Powell, C., Pratt, B., Harrington, K., Nutting, C., Harmer, C., Newbold, K. (2013) Long-Term Outcomes Following Low-Dose Radioiodide Ablation for Differentiated Thyroid Cancer. Journal of Clinical Endocrinology & Metabolism, 98 (5). pp. 1819-1825. ISSN 0021-972X

Nutting, C. M., van Herpen, C. M. L., Miah, A. B., Bhide, S. A., Machiels, J. P., Buter, J., Kelly, C., de Raucourt, D., Harrington, K. J. (2009) Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma. ANNALS OF ONCOLOGY, 20 (7). pp. 1275-1279. ISSN 0923-7534

Gujral, D. M., Chahal, N., Senior, R., Harrington, K. J., Nutting, C. M. (2014) Radiation-induced carotid artery atherosclerosis. RADIOTHERAPY AND ONCOLOGY, 110 (1). pp. 31-38. ISSN 0167-8140

Murray, J. R., Williams, G. R., Harrington, K. J., Newbold, K., Nutting, C. M. (2012) Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm? CLINICAL ENDOCRINOLOGY, 77 (1). ISSN 0300-0664

Kazi, R., Nutting, C. M., Rhys-Evans, P., Harrington, K. J. (2009) A Short Perspective on the Surgical Restoration of Alaryngeal Speech. SOUTHERN MEDICAL JOURNAL, 102 (8). pp. 838-840. ISSN 0038-4348

Dwivedi, R. C., Kazi, R., Kanwar, N., Nutting, C. M., Harrington, K. J., Rhys-Evans, P. H. (2011) Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus? ANZ JOURNAL OF SURGERY, 81 (9). pp. 581-583. ISSN 1445-1433

Bhide, S. A., Davies, M., Burke, K., McNair, H. A., Hansen, V., Barbachano, Y., El-Hariry, I. A., Newbold, K., Harrington, K. J., Nutting, C. M. (2010) WEEKLY VOLUME AND DOSIMETRIC CHANGES DURING CHEMORADIOTHERAPY WITH INTENSITY-MODULATED RADIATION THERAPY FOR HEAD AND NECK CANCER: A PROSPECTIVE OBSERVATIONAL STUDY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 76 (5). pp. 1360-1368. ISSN 0360-3016

Miah, A. B., Bhide, S. A., Guerrero-Urbano, M. T., Clark, C., Bidmead, A. M., St Rose, S., Barbachano, Y., A'Hern, R., Tanay, M., Hickey, J., Nicol, R., Newbold, K. L., Harrington, K. J., Nutting, C. M. (2012) DOSE-ESCALATED INTENSITY-MODULATED RADIOTHERAPY IS FEASIBLE AND MAY IMPROVE LOCOREGIONAL CONTROL AND LARYNGEAL PRESERVATION IN LARYNGO-HYPOPHARYNGEAL CANCERS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82 (2). pp. 539-547. ISSN 0360-3016

Nutting, C. M., Morden, J. P., Beasley, M., Bhide, S., Cook, A., De Winton, E., Emson, M., Evans, M., Fresco, L., Gollins, S., Gujral, D., Harrington, K., Joseph, M., Lemon, C., Luxon, L., van den Blink, Q., Mendes, R., Miah, A., Newbold, K., Prestwich, R., Robinson, M., Sanghera, P., Simpson, J., Sivaramalingam, M., Srihari, N. N., Sydenham, M., Wells, E., Witts, S., Hall, E., Investigators, Costar (2018) Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004). EUROPEAN JOURNAL OF CANCER, 103. pp. 249-258. ISSN 0959-8049

Welsh, L., Panek, R., Riddell, A., Wong, K., Leach, M. O., Tavassoli, M., Rahman, D., Schmidt, M., Hurley, T., Grove, L., Richards, T., Koh, D. M., Nutting, C., Harrington, K., Newbold, K., Bhide, S. (2017) Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck. BRITISH JOURNAL OF CANCER, 116 (1). pp. 28-35. ISSN 0007-0920

Powell, C., Schmidt, M., Borri, M., Koh, D. M., Partridge, M., Riddell, A., Cook, G., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L. (2013) Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. RADIOTHERAPY AND ONCOLOGY, 106 (1). pp. 112-117. ISSN 0167-8140

Panek, R., Schmidt, M. A., Borri, M., Koh, D. M., Riddell, A., Welsh, L., Dunlop, A., Powell, C., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L., Leach, M. O. (2016) Time-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected? MEDICAL PHYSICS, 43 (11). pp. 6024-6032. ISSN 0094-2405

Dunlop, A., McQuaid, D., Nill, S., Murray, J., Poludniowski, G., Hansen, V. N., Bhide, S., Nutting, C., Harrington, K., Newbold, K., Oelfke, U. (2015) Comparison of CT number calibration techniques for CBCT-based dose calculation. STRAHLENTHERAPIE UND ONKOLOGIE, 191 (12). pp. 970-978. ISSN 0179-7158

Gurney-Champion, O. J., McQuaid, D., Dunlop, A., Wong, K. H., Welsh, L. C., Riddell, A. M., Koh, D. M., Oelfke, U., Leach, M. O., Nutting, C. M., Bhide, S. A., Harrington, K. J., Panek, R., Newbold, K. L. (2018) MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 100 (2). pp. 306-316. ISSN 0360-3016

Lee, J. Y., Garcia-Murillas, I., Cutts, R. J., De Castro, D. G., Grove, L., Hurley, T., Wang, F. Q., Nutting, C., Newbold, K., Harrington, K., Turner, N., Bhide, S. (2017) Predicting response to radical (chemo) radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma. BRITISH JOURNAL OF CANCER, 117 (6). pp. 876-883. ISSN 0007-0920

Buettner, F., Miah, A. B., Gulliford, S. L., Hall, E., Harrington, K. J., Webb, S., Partridge, M., Nutting, C. M. (2012) Novel approaches to improve the therapeutic index of head and neck radiotherapy: An analysis of data from the PARSPORT randomised phase III trial. RADIOTHERAPY AND ONCOLOGY, 103 (1). pp. 82-87. ISSN 0167-8140

P

Newbold, K., Partridge, M., Cook, G., Sohaib, A., Charles-Edwards, E., Rhys-Evans, P., Harrington, K., Nutting, C. (2006) Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. BRITISH JOURNAL OF RADIOLOGY, 79 (943). pp. 554-561. ISSN 0007-1285

W

Nutting, C. M., Normile, P. S., Bedford, J. L., Harrington, K. J., Webb, S. (2003) A systematic study of techniques for elective cervical nodal irradiation with anterior or opposed anterior and posterior beams. RADIOTHERAPY AND ONCOLOGY, 69 (1). pp. 43-51. ISSN 0167-8140

Rogers, S. J., Box, C., Chambers, P., Barbachano, Y., Nutting, C. M., Rhys-Evans, P., Workman, P., Harrington, K. J., Eccles, S. A. (2009) Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck. JOURNAL OF PATHOLOGY, 218 (1). pp. 122-130. ISSN 0022-3417

This list was generated on Wed Nov 14 01:04:15 2018 UTC.

Export as	RSS

Items where Division or Clinical Unit is:ICR divisions > Cancer Biology > Targeted TherapyICR divisions > Radiotherapy and Imaging > Targeted Therapy

A

B

D

E

G

H

K

L

M

N

P

W

Items where Division or Clinical Unit is:
ICR divisions > Cancer Biology > Targeted Therapy
ICR divisions > Radiotherapy and Imaging > Targeted Therapy